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Reconstruction of lost or damaged cartilaginous structures of the temporomandibular 
joint (TMJ) presents a clinical challenge and current treatment options are limited. The 
potential for repair is poor, because cartilage is avascular and degenerated structures 
are traditionally surgically removed, to improve function and reduce the level of pain. 
The studies in this thesis were undertaken to explore the possibility for regeneration of 
TMJ cartilage by means of tissue engineering (TE). The main objective of this thesis 
was to develop a regenerative approach for degenerated TMJ cartilage, combining bone 
marrow-derived stem cells (BMSC) with a natural polymer scaffold. 
Study I is a pilot study, investigating the in vivo effect of the angiogenesis inhibitor, 
angiostatin, on BMSC seeded collagen scaffolds. After subcutaneous implantation in 
rats for two weeks, angiostatin downregulated the levels of inflammatory and 
angiogenic gene markers and decreased vessel formation in the constructs. However, 
histological examination disclosed that this strategy alone did not induce cartilage 
formation.  
Based on the above findings, and the observed lack of established methods for TMJ 
cartilage TE, a systematic literature review (Study II) was undertaken to assess the in 
vivo evidence for TMJ TE. In total, the search yielded 30 studies of ectopic and 
orthotopic models investigating regeneration of the TMJ disc, condyle, and synovial 
membrane, in five different species. Overall, the use of BMSC and natural polymer 
scaffolds was most frequently reported. With respect to regenerative potential, 
differentiated stem cells were reported to be superior to undifferentiated cells.  
The systematic review disclosed the beneficial effects of BMSC combined with 
scaffolds of natural polymers, such as collagen and gelatin. With respect to TMJ 
regeneration by TE, the preferred scaffolding material for investigation was gelatin, 
because of its biocompatibility, superior hydrogel-forming properties and lower costs 
in comparison with collagen. In Study III, a gelatin hydrogel was 3D printed, 
crosslinked with genipin and characterized in terms of swelling, stability, degradation, 
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mechanical properties and cytotoxicity. The chondrogenic differentiation potential of 
human BMSC (hBMSC) seeded on the developed scaffolds was compared with that of 
hBMSC in traditional pellet or novel spheroid cultures. Genipin successfully prevented 
rapid degradation of the scaffolds, which supported cell attachment and proliferation 
without adverse cytotoxic effects. Scaffolds seeded with hBMSC followed the same 
trend in upregulation of chondrogenic gene markers, but at lower levels than for pellet 
and spheroid cultures. It was noteworthy that the hypertrophy marker collagen type 10 
was downregulated in hBMSC on scaffolds, in comparison with spheroids and cell 
pellets. The chondrogenic differentiation of hBMSC on the 3D printed scaffolds was 
confirmed by Alcian blue and immunofluorescence staining.  
In Study IV, dehydrothermal (DHT) treatment was compared to ribose and the dual 
crosslinking with both DHT and ribose. The scaffolds were characterized with respect 
to swelling, stability, enzymatic degradation, and degree of crosslinking. Cell-seeding 
efficiency, attachment, proliferation, glycosaminoglycan (GAG) formation and 
differentiation of rat BMSC were compared between the groups. While the dual 
crosslinking resulted in the highest degree of crosslinking, stability, enzymatic 
resistance, mechanical properties, and proliferation, DHT had the highest cell seeding 
efficiency and viability. Ribose had the highest swelling capacity, but the lowest 
stability, enzymatic degradation, mechanical properties, cell seeding density and 
chondrogenic differentiation potential. However, no differences were observed with 
respect to GAG formation. 
In summary, inhibition of vascularization alone was not enough to stimulate 
chondrogenesis in TE constructs (Study I), indicating the need for alternative 
approaches. The current preclinical evidence clearly demonstrates the beneficial effects 
of using natural polymer scaffolds combined with MSC for TMJ TE (Study II).  
Gelatin, one such polymer, was found to be suitable for fabrication of 3D printed 
scaffolds, which support the proliferation and chondrogenic differentiation of hBMSC 
(Study III). Finally, dual crosslinking of 3D printed gelatin scaffolds with DHT and 
ribose enhanced the degree of crosslinking, mechanical properties, enzymatic 
resistance and stability (Study IV).  
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1.  Introduction 
1.1. Clinical challenge 
Temporomandibular disorders (TMD) are a subgroup of multifactorial craniofacial 
pain conditions, clinically manifest in the musculoskeletal structures of the head and 
neck [1]. The prevalence in the population is 3-12 % [2, 3] and reportedly more 
frequent (2-9 times) in women than men [1, 4]. The temporomandibular joint (TMJ) is 
a bilateral synovial joint (Figure 1) with both sliding- and hinge movements, of great 
importance for daily activities such as speaking and chewing [5]. It connects the 
mandible to the temporal fossa and is separated by a disc [6]. The disc provides 
lubrication for smooth movements, in addition to absorbing loads during mastication, 
in many ways analogous to the meniscus in the knee. The disc is composed of 
fibrocartilage, in which the main component is collagen type 1 (COL1), with a 
biconcave shape to fit the mandibular condyle [7]. The mandibular condyle has a 
superficial layer of fibrocartilage, but with additional zones of COL2 dominated 
hyaline cartilage-like architecture, with proliferative, mature and hypertrophic zones, 
towards the underlying bone [8]. In a healthy situation, the disc follows the condylar 
movements. 
Displacement of the TMJ disc, most commonly anteriorly, which interferes with 
smooth joint movements, is called internal derangement (ID) [9]. The displacement can 
be reversible, associated with painful clicking, or constitute a sustained mechanical 
obstacle, i.e. chronic closed lock [10]. ID is considered to be a TMD and is often 
conjugated with osteoarthritis (OA), but it is unclear whether they are causative events, 
or if one precedes the other [11]. Nevertheless, the trauma to the disc can over time 
lead to disc thinning and perforations, which are considered to be the first of a series 
of degenerative changes [12, 13].  
Degenerative joint diseases constitute a significant global health problem [14], 
expected to increase as the population ages [15]. OA is the most prevalent joint disease 
[16] and leads to breakdown of cartilaginous and bony structures, resulting in impaired 
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function and quality of life [17]. Degenerative changes are most frequently observed 
in load-bearing joints, e.g. knee and spine, but are also a frequent finding in the TMJ 
[18]. Risk factors for OA development include joint injury, obesity, aging and heredity. 
However, the molecular mechanisms underlying initiation and progression of OA in 
general [19] and TMJ OA specifically [20], are elusive and poorly understood. 
Moreover, the lack of blood and nerve supply within cartilaginous tissues contributes 
to low repair potential and lesion progression [21]. 
 
Figure 1. The temporomandibular joint and associated structures.  
Most TMD are treated with non- or minimally invasive approaches, such as physical 
therapy, occlusal splints, pharmacological agents, intra-articular injections, 
arthrocentesis and arthroscopy [1]. However, approximately 5-10 % of patients who 
seek treatment for TMD do not respond to conservative treatment [22] and fewer than 
1 % are candidates for surgical interventions [23]. In some cases, the diseased TMJ 
disc is surgically removed (discectomy) [24] and postoperatively improved function 
and decreased pain are reported [25], but to prevent further degeneration, and in severe 
cases ankylosis of the mandible to the temporal bone, a interpositional disc replacement 
material is often recommended [26].  
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In the 1970’s and 80’s alloplastic silicone-rubber and polytetrafluoroethylene (PTFE) 
implants were used, with catastrophic long-term clinical results [27]: material 
fragmentation and foreign body reactions with giant cell infiltrates due to 
biomechanical overloading were observed in the TMJ [27]. Since then, autologous 
grafts of dermis and/or fat, or temporal muscle are preferred [26]. These provide 
temporary replacements to cover the osteotomized bone surfaces during healing, but 
require more invasive surgery with associated donor site morbidity [28]. Insertion of a 
total joint prosthesis, completely replacing the condyle and fossa component with an 
alloplastic device, is a biomechanical solution reserved for a small group of end-stage 
TMD patients [29]. Despite improved long-term success of the devices, the complexity 
of the physiological and biomechanical  environment affects the longevity [29]. Hence, 
revisions during the patient’s lifetime are likely, with associated increased costs and 
patient-burden [30]. 
Thus, there is currently a gap in treatment options available for repair of TMJ structures 
damaged by degenerative TMJ changes [20].  
1.2. Cartilage Tissue Engineering (CTE) 
Historically, fibrocartilage injuries have been treated by removal of the affected 
structures [31], e.g. knee meniscectomy [32], or TMJ discectomy [25]. While this may 
increase the function and decrease the symptoms, it does not repair and restore the lost 
or damaged functional structures. This has led to a paradigm shift, towards regenerative 
strategies. Pioneering work by Langer and Vacanti, using three dimensional (3D) 
porous scaffolds to culture cells [33] has evolved into what is today referred to as tissue 
engineering (TE). The concept includes the use of cells from the patient, often 
combined with biomaterial(s) serving as a template/scaffold for regeneration and 
neotissue formation [34]. It has been proposed that cartilage, a homogenous, avascular 
tissue containing few cell types, would be an ideal candidate for CTE [35].  
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1.2.1. Cell types 
Chondrocytes   
Chondrocytes (CC), which comprise the cellular component of cartilage, are mature 
cells with the inherent ability to secrete cartilaginous matrix. They have therefore been 
widely used in attempts at cartilage regeneration [36]. An early study and one of the 
most renowned, is from Vacanti’s group, who seeded bovine CC onto polyglycolic acid 
(PGA) scaffold with the anatomical shape of a human ear [37]. After 12 weeks of 
subcutaneous implantation in athymic mice, the construct successfully formed 
neocartilage. In orthopedics, autologous chondrocyte implantation (ACI), i.e. 
harvesting and expansion of CC before re-transplantation [38], and microfracture 
marrow stimulation, i.e. perforating the site of injury to recruit progenitor cells for 
repair, are established clinical methods with varied success in replicating native tissue 
[35].  
Despite the established clinical application of ACI in orthopedics [39], there are few 
such studies on the TMJ. An exception is a recent study reporting injection of 
autologous nasal septum-derived CC for regeneration of condylar resorption after 
orthognathic surgery [40]. Six months after injection of 10 million cells per TMJ, 
computed tomography (CT) images revealed regeneration of cartilaginous and bony 
defects. One year later, CT images revealed cortical and subcortical bone formation, 
partially reconstructing the original anatomy. Albeit a single case, this study presents 
a concept for cell-based condylar regenerative treatment, preventing or delaying the 
need for an alloplastic total joint prosthesis [40].  
CC have been harvested from numerous sites for various CTE applications, for 
example hyaline cartilage CC from costal ribs [41, 42], articular joints [41] and nose 
[43], elastic cartilage from the ear [44] and fibrocartilage CC harvested from the TMJ 
condyle [45] and intervertebral disc (IVD) annulus fibrosis [46]. Although CC are 
considered to be immune privileged, the potential use of allogenic CC is still limited 
by donor availability and the risk of disease transmission [36]. Harvesting of CC 
requires secondary surgery, with associated donor site morbidity and risk of 
complications [35]. For example, apart from infections, OA development has been 
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reported even from small biopsies from non-weight bearing joints [21]. Furthermore, 
in vitro expansion for adequate cell numbers has demonstrated limited life span, loss 
of phenotype through dedifferentiation and senescence of the CC [47] with decreased 
matrix secretion [36], making them less than ideal candidates for cell-based CTE.  
Mesenchymal stem cells 
The limitations of CC have led to investigation of alternative cell sources. The potential 
of mesenchymal stem cells (MSC) has been widely investigated for several 
applications after their discovery by Friedstein et al. in 1968 [48]. MSC are multipotent 
cells with the ability to differentiate into cells of mesodermal origin, e.g. bone, fat, 
muscle, tendon and cartilage [49]. They were first isolated from bone marrow (BMSC), 
and consequently most extensively investigated [49]. However, the fraction of MSC is 
limited to 0.001% - 0.01% of the total number of bone marrow nucleated cells [50]. 
This requires massive in vitro expansion to achieve adequate cell numbers for clinical 
use. In contrast to CC, MSC can be expanded with lower risk of losing their phenotype 
[38]. Furthermore, MSC need to be characterized to ensure that they meet the minimal 
criteria defined by The International Society for Cellular Therapy (ISCT) i.e. plastic 
adherence, tri-lineage differentiation capacity and cluster of differentiation (CD) and 
human leukocyte antigen DR isotype (HLA-DR) surface marker expression (CD73+, 
CD90+, CD105+, CD34−, CD45−, HLA-DR−) [51]. These characteristics enable MSC 
to be distinguished from hematopoietic cells, but may still not ensure homogenous 
MSC populations [36]. Due to the invasiveness of bone marrow aspirations, alternative 
sources have been explored, e.g. adipose tissue, synovial tissue, dental pulp  and others 
[52]. ASC are more abundant and easily accessed than BMSC, but with reportedly 
inferior chondrogenic differentiation potential [36, 53, 54].  
Regardless of the source, individual donor variability of MSC is a challenge with 
respect to proliferation and differentiation capacity [54], which may require tuning of 
cell density on a donor-by-donor basis for successful stable neotissue formation [55]. 
Furthermore, the time and cost of individual monolayer expansion in a Good 
Manufacturing Practice (GMP) facility to obtain the required cell numbers may limit 
their applications [36]. 
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MSC contribute to repair and regeneration by differentiating into specific cell types, 
and/or secreting soluble bioactive molecules (e.g. growth factors [GFs], cytokines and 
chemokines). It is proposed that these trophic or paracrine effects which stimulate host 
progenitor cells and modulate immune cells [56], are the main effect of MSC in 
regeneration and the reason Caplan argues that MSC should be referred to as ‘medicinal 
signaling cells’ [57]. The paracrine effects of MSC have recently been reported 
clinically [58]. Allogenic MSC were co-cultured with autologous articular cartilage-
derived cells (including pericellular matrix) in a 90:10 or 80:20 ratio for treatment of 
isolated articular defects in the knee of 10 young patients (mean 26 ± 5 years) [58]. The 
cells were mixed with fibrin glue and implanted without adverse effects, proving the 
safe clinical use of allogenic MSC. The defects healed and were close to ‘normal tissue’ 
in six patients and ‘nearly normal’ in three of the nine patients approving a second-look 
arthroscopy at 12-month follow-up. No allogenic cells were present in the repair tissue 
after 1 year and no immune responses were observed. The authors proposed that the 
MSC served as a “drug-store” [59], providing a regenerative microenvironment and 
regulating the immune response in vivo.   
Chondrogenic differentiation of MSC 
Chondrogenic differentiation is regulated by several signaling pathways [60]. 
Embryonically, MSC condensations result in SRY-related high-mobility group-box 
gene 9 (SOX9) expression which is considered a key regulator of chondrogenesis [61]. 
Expression of transcription factors SOX5, SOX6 together with SOX9 are seen in 
immature CC, together with the proteins COL2 and aggrecan (ACAN), all considered 
markers for CC differentiation [60]. SOX9 is expressed in healthy cartilage throughout 
life but repressed in hypertrophic CC [62]. Heterozygous mutations of this gene lead 
to severe skeletal malformations, e.g. campomelic dysplasia, dwarfism, cleft palate and 
can be potentially lethal when affecting the airways [62, 63]. SOX9 also regulates other 
chondrogenic genes, e.g. ACAN [64] and COL2 [65]. ACAN is a major structural core 
protein in cartilage and categorized as a proteoglycan [66]. With connected 
glycosaminoglycans (GAG) it forms hydrated gels, considered crucial for the load-
bearing capacity of cartilage [66].  
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A standard method for in vitro chondrogenic differentiation is by means of MSC 
aggregated in pellets and cultured in chondrogenic defined medium [67, 68]. The high 
density and close proximity stimulate communications through diffusible signals and 
cell-cell interactions, and aims to mimic the embryological mesenchymal 
condensations [60, 67]. The medium is typically supplemented with dexamethasone, 
ascorbate-2-phosphate, insulin, selenious acid, transferrin, sodium pyruvate and 
transforming growth factor beta [69]. After two to three weeks of pellet culture, ECM 
with primary cartilage-specific molecules e.g. COL2 and ACAN, is expected to be 
present [69]. However,  nutrient supply to the core of the pellet is limited, resulting in 
necrosis [70]. 
While pellet cultures have been used for chondrogenic differentiation for decades, 
more recently, aggregated cell cultures of MSC have attracted interest for several 
applications [71]. To overcome the limitations of monolayer cultures such as altered 
immune properties and low survival rate post-transplantation, smaller sized aggregates, 
i.e. cell spheres, have been investigated [71, 72]. Enhanced anti-inflammatory and 
regenerative effects, in addition to enhanced cell survival after transplantation and 
differentiation potential have been described [73]. Cell spheres can be formed by 
different techniques e.g. self-assembling in ultra-low attachment wells, hanging drop 
or microwell plates [73]. These methods are common for pluripotent stem cells and 
embryoid body formation, as the 3D culture replicates the intercellular interactions of 
embryonic cells [74]. While the self-assembly process and hanging drop technique are 
easy to implement, they result in poor standardization with respect to size, viability and 
efficiency [75]. However, microwell plates have emerged as a high-throughput method 
to control size and preserve viability [68, 76, 77].  
Hypertrophy, a challenge of differentiated MSC, is associated with increased 
expression of COL10, alkaline phosphatase (ALP), matrix metalloproteinase 13 
(MMP13) and vascular endothelial growth factor (VEGF), with decreased levels of 
chondrogenic differentiation markers [36]. This leads to invasion of osteogenic and 
endothelial cells replacing the cartilage template by bone through endochondral 
ossification [38, 60], an undesired outcome for engineered cartilage. Several strategies 
 26
to minimize this limitation have been proposed [38]. Co-culture of MSC and CC have 
been reported as promising [78], but would not obviate the need for CC harvesting. 
Alternative sources of MSC have been investigated, and synovium-derived MSC have 
displayed decreased hypertrophy potential, compared to BMSC and ASC [79]. Others 
have sought to suppress angiogenesis by using strategies intended to inhibit vascularity 
of either cells [80] or scaffold [81].    
1.2.2. Scaffolds 
Traditional two-dimensional cell cultures do not replicate the various 3D 
microenvironments in the human body [82]. Scaffold-free approaches, i.e. self-
assembly and self-organization strategies, are 3D cultures using high cell densities to 
stimulate matrix secretion and lead to mature implants which integrate more easily 
[83]. However, this strategy is limited to smaller defects and is less applicable to more 
extensive replacements and defects. Hence, the current project focused on scaffold-
based strategies. The goals of biomaterial scaffolds are to simulate the native in vivo 
ECM for implanted cells, stimulating proliferation and differentiation and to recruit 
endogenous progenitor cells to induce regeneration. Irrespective of the targeted tissue, 
a scaffold must possess the following properties [82] – (a) the material(s) should 
replicate the native tissue geometry (i.e. size and shape) to fill and replace the desired 
defect(s), (b) it should be biodegradable at a rate matching the formation of new tissue, 
and (c) the degradation products should be removed without provoking inflammatory 
host responses [84]. To fulfill all these requirements is challenging.   
A wide range of biomaterials has been investigated for CTE. Broadly, they can be 
divided into synthetic and natural polymers, or hybrid mixtures of the two [85]. 
Synthetic polymers can be tailored with respect to their mechanical properties and 
degradation rate [86], important features for cartilage regeneration. Polycaprolactone 
(PCL) with microsphere-incorporated GFs have been used without implanted cells for 
TMJ disc defect regeneration [87] and polylactide (PLA) has been investigated for TMJ 
disc implants [88]. However, in addition to acidic degradation products, synthetic 
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polymers tend to have hydrophobic surface properties, which can prevent cell adhesion 
and protein absorption [86]. 
Natural polymers such as collagen, gelatin, fibrin, chitosan and silk are widely used 
[82]. The natural origin mimics the native ECM and are biocompatible and 
biodegradable. However, limitations are weak mechanical properties and in vivo 
stability. Hybrid composite materials of natural and synthetic polymers have been 
developed to overcome the limitations of single polymer materials. The hydrophobicity 
of synthetic polymers can be modified by incorporating functional ligands from natural 
materials. Weak mechanical properties can be enhanced by incorporating synthetic 
polymers [82] or by using different methods to cure the material, e.g. crosslinking.  
Collagen as scaffold biomaterial 
Collagen is the most abundant protein in mammals, present in several tissues, such as 
cartilage, bone and tendons, and constitutes about 30 % of the body’s total protein 
content [89, 90]. The collagen molecule forms a triple helix of three α-chains of 
approximately 1000 amino acids each, with a molecular weight of 100 kDa [89]. At 
least 29 different types of collagen have been identified in vertebrates and 
invertebrates, with differences in sequence, structure and function [89] – all with the 
primary function of structurally stabilizing tissues and organs.  
Collagen contains the amino acid ligands of Arginine-Glycine-Aspartate (RGD 
sequences), which are important binding motifs for cell attachment, able to initiate an 
intracellular signaling pathway, which stimulates cellular proliferation and 
maintenance of phenotype [91]. Because of its abundancy, biocompatibility and 
biodegradability, COL1 is a major fibrillar type most commonly used as scaffold 
biomaterial for CTE [91]. While COL1 is the main constituent in fibrocartilage [7], 
COL2 is the major component of articular hyaline cartilage and for this reason has been 
proposed to support chondrogenic stimulation [91]. However, COL2 has reportedly 
arthritogenic potential and has failed to gain approval by several health agencies, thus 
limiting clinical application [91].  
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Gelatin as scaffold biomaterial 
Gelatin has been used for decades in food, cosmetics and pharmaceuticals [92] and is 
recognized as Generally Regarded As Safe (GRAS) by the United States Food and 
Drug Administration (FDA) [93]. Gelatin is a heterogeneous mixture of peptides [89] 
of natural origin derived from chemical hydrolysis of collagen [94]. The triple helical 
structure of collagen can be denatured by either acidic (type A) or alkaline (type B) 
hydrolysis [92], breaking up the tertiary structure [94]. The most common source of 
gelatin is porcine and bovine skin for type A and type B, respectively [95]. The alkaline 
treatment leads to a higher carboxylic acid content in type B [90]. Gelatin has several 
advantages for biomedical applications: low costs, high hydrophilicity, 
biocompatibility and biodegradability [96]. The abundant RGD sequences ensure cell 
attachment without compromising the cell phenotypes. However, gelatin derived from 
pigskin is the only source containing aspartic acid, which is an essential amino acid in 
the RGD sequence [97].  
Collagen and gelatin can form both porous scaffolds and hydrogels for 3D printing 
[90]. However, they have poor mechanical properties and in vivo stability [94, 98]. 
These properties can be improved by crosslinking, with plentiful options due to the 
many functional groups accessible for chemical or physical modification [92].  
Scaffold crosslinking 
Crosslinking induces links between the polymer chains, forming 3D networks. The 
process may be generally described as enzymatic, chemical or physical , depending on 
the methods used to tailor the mechanical, biological and degradation properties of the 
material [99]. For TE applications, the cytotoxicity of the material and crosslinking 
agents are important factors, as cellular responses can be influenced by both the 
crosslinking agents and the soluble products that may leach out.  
Enzymatic crosslinking includes microbial transglutaminase (mTGase), horseradish 
peroxidase and hydrogen peroxide. These methods provide mild reaction conditions, 
high efficiency and good cytocompatibility [99]. For TE applications, mTG is one of 
the most frequently applied methods of crosslinking collagen and gelatin scaffolds [99, 
100].  
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Chemical crosslinking by glutaraldehyde (GTA) is widely used due to the low cost and 
high efficacy [99]. In addition to polymer scaffolds it is used to crosslink artificial 
cardiovascular prostheses from decellularized ECM (allogenic and xenogenic) [101]. 
However, calcification of the constructs are reported [101], an undesired outcome for 
both vascular prostheses and CTE. Moreover, the aldehyde groups are cytotoxic and 
can potentially cause severe inflammation during degradation.  
Genipin is a natural, chemical crosslinker extracted by hydrolysis from the fruit 
Gardenia jasminoides [99]. In addition to promising biological properties [102], it has 
been shown to be an efficient crosslinker [99].  It forms dark blue pigments within the 
matrix by bridging lysine or hydroxylysine of the polypeptide chains [103] of various 
natural polymers, e.g. chitosan, collagen and fibrinogen [104-106]. However, the high 
costs may limit mass production [99]. In contrast, sugar, e.g. ribose or glucose, is an 
inexpensive and accessible alternative for chemical crosslinking. The crosslinking 
efficiency of ribose is reported to be higher than for glucose, but the reactions are 
similar [107]. The crosslinking is initiated by the Maillard reaction which generates 
advanced glycosylated end products (AGEs) [55] leading to glycation of free amino 
acids and proteins, improving mechanical strength and resistance to degradation [56, 
57].  
Dehydrothermal (DHT) treatment is a physical crosslinking method that combines 
vacuum and high temperature (>100 °C) over time. Water molecules are removed and 
two complementary functional groups are bonded through esterification or amide 
formation, preventing the fibers from sliding past each other under stress [108]. This 
method is free from chemical reagents and has been reported to be superior to chemical 
genipin crosslinking for cartilage regeneration [108]. In addition to stabilization, DHT 
treatment also sterilizes the material, increases cellular activity and decreases the 
immunogenic response [109]. 
3D printed scaffolds 
Fabrication methods for scaffolds have evolved over time. Traditionally, porous 
scaffolds have been fabricated by ‘moulding’ followed by freeze-drying, ‘solvent 
casting and particular leaching’ or ‘gas foaming’ [82]. Freeze-drying of a frozen 
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polymer solution removes ice crystals under vacuum directly from the solid phase to 
gas – resulting in a dry, porous structure. Solvent casting and particular leaching use 
porogens in a polymer-solvent solution that are dissolved after moulding. Gas foaming 
creates pores by gas (e.g. carbon dioxide) bubbles of a solid polymer, eliminating the 
need for solvents [110]. While these methods are easy and inexpensive, they are limited 
by the control of pore size, interconnectivity, geometry and reproducibility [110].  
Advances within rapid prototyping and additive manufacturing have emerged, known 
as 3D printing. In this process, scaffolds are created by means of a computer-aided 
design (CAD) model which can be obtained from medical imaging methods, e.g. CT 
or magnetic resonance imaging (MRI). The CAD object is sliced in cross-sectional 
layers of preferred thickness, depending on the nozzle size used to print the project. 
The CAD file instructs the printer head in movements in x, y and z-directions and the 
software allows adjustments of parameters, e.g. pressure, speed and temperature, 
depending on the material properties. This facilitates controlled pore size and 
customized geometry to fit the defect and permits creation of regional variances 
reminiscent of the native structure [111]. 
Different 3D printing methods have been used for scaffold fabrication. A common 
method today is extrusion-based printing that utilizes pneumatic pressure to extrude a 
soft polymer through the nozzle of the printing head, to the platform, and is compatible 
with both synthetic and natural polymers.  
1.2.3. Preclinical TMJ models 
To test the efficacy of experimental therapy, preclinical animal models are applied in 
both small and large animal models. Preclinical testing is important for translational 
research and often a requirement for regulatory health agencies before initiation of 
clinical trials [112]. Small animals like mice, rats and rabbits are often used for proof 
of principle studies [112] due to their low cost, easy handling and housing conditions 
compared to larger animals [113]. Mice and rats are commonly used for degenerative 
joint disease models, which can be either chemically induced (for pain), surgically 
induced (to mimic degenerative defects) or mechanically induced (to investigate 
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structure and function) [114]. Also widely used are ectopic models like subcutaneous 
implantation, and immunocompromised animals are used for xenograft 
implantation(s). The small size of rodent’s TMJ limits their use for orthotopic models. 
It is possible however, to conduct experimental TMJ surgery in rabbits [87, 88]. Larger 
animals, like dogs, sheep, goats, farm pigs and minipigs, are more costly, but more 
closely resemble clinical conditions with respect to anatomy and function and can 
better predict the therapeutic efficacy [114]. However, animal models will never fully 
replicate the disease pathogenesis, morphology, forces, and function of a clinical 
setting. 
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2. Rationale  
Degenerative joint diseases are prevalent and expected to increase as the population 
ages. The poor potential of cartilage for self-repair, often results in progressive lesions 
with associated disability. For patients suffering from degenerative TMJ diseases, there 
is a gap between early, conservative, and minimally invasive treatment options and 
end-stage surgical treatments with discectomy or total joint prostheses. Previous 
reports of failures from alloplastic TMJ disc implants and incomplete preclinical 
investigations, highlight the importance of thorough in vitro and in vivo testing. 
Extensive research has been conducted into regenerating lost and damaged 
cartilaginous structures. Within orthopedics, articular hyaline cartilage and knee 
meniscus fibrocartilage have been investigated more extensively than TMJ structures. 
CC are often used due to their inherent ability to secrete cartilaginous matrix – but 
clinical applicability is limited because of the invasive harvesting procedure and donor 
site morbidity. BMSC have chondrogenic differentiation potential and the harvesting 
is less invasive. Although promising results have been reported for several applications, 
hypertrophic transformation is an obstacle frequently reported when BMSC are 
differentiated into the chondrogenic lineage. Several scaffold biomaterials have been 
used, but the results from the alloplastic disc implants highlight the importance of 
developing optimized, biocompatible clinical implants. Natural polymers are 
biodegradable and biocompatible, and some can form 3D printable hydrogels. Additive 
manufacturing allows for customized geometry and controlled porosity, compared to 
traditional scaffold fabrication methods. Collagen is an obvious candidate, considering 
the composition of fibrocartilage. However, gelatin has many of the same advantages 
at a lower cost. The disadvantages of using natural polymers are their weak mechanical 
properties and thermo-instability, which necessitates crosslinking. Traditional 
crosslinkers, e.g. GTA and formaldehyde, are reported to be cytotoxic. Therefore, 
alternative methods need to be explored.  
In this context, the present thesis describes research into in vivo and in vitro methods 




The main objective of this thesis was to develop a regenerative approach for 
degenerated TMJ cartilage, combining BMSC with a natural polymer scaffold. The 
specific aims for each study were as follows:  
Study I 
To investigate the effect of angiostatin on inhibiting angiogenesis in collagen scaffolds 
loaded with rat BMSC in vivo as a strategy for cartilage regeneration.  
Study II 
To conduct a systematic review of the literature, for preclinical evidence of scaffold-
based TE approaches for cartilage regeneration.  
Study III 
To develop and characterize (mechanically and biologically) 3D printed gelatin 
scaffolds, crosslinked with genipin for cartilage regeneration.  
Study IV 
To evaluate different crosslinking methods for 3D printed gelatin scaffolds developed 
for cartilage regeneration.  
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4. Materials and methods 
4.1. Thesis design 
 
Figure 2. Schematic summary of the study designs used in the thesis.  
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4.2. Materials  
Table 1. Materials and equipment used in the thesis 
Description Supplier Study 
Materials 
Collagen I scaffolds Optimaix 3D, Matricel GmbH, 
Herzogenrath, Germany 
I 
Angiostatin Merck Millipore, MA, USA I 
Gelatin Type A Sigma-Aldrich, MO, USA III, IV 
Genipin  Wako Chemicals GmbH, Neuss, 
Germany 
III 
Ethanol Sigma-Aldrich, MO, USA III 
Alpha minimum essential 
medium 
αMEM, Gibco, Thermo Fischer 
Scientific, MA, USA 
I, III, IV 
Heparin Leo Pharma A/S, Ballerup, Denmark III 
Bovine serum albumin Sigma-Aldrich, MO, USA III 
Cell culture flasks NUNC A/S, Roskilde, Denmark I, III, IV 
Penicillin/streptomycin HyClone, GE Healthcare, IL, USA I, III, IV 
FBS HyClone, GE Healthcare, IL, USA I, III, IV 
Chondrogenic medium StemPro, Thermo Fischer Scientific, 
MA, USA 
III, IV 
Adipogenic medium Stem Pro Adipogenesis Differentiation 
Kit (Gibco, Thermo Fischer Scientific) 
III 
PBS Invitrogen, Thermo Fischer Scientific, 
MA, USA 
I, III, IV 
Triton-X (0.1% in PBS) Sigma-Aldrich, MO, USA III, IV 
PicoGreen Quant-IT, Thermo Fischer Scientific, 
MA, USA 
III, IV 
DAPI Sigma-Aldrich, MO, USA I, III, IV 
RNAlater Invitrogen, Thermo Fischer Scientific, 
MA, USA 
I 
RNA extraction kit Maxwell, Promega, WI, USA I, III, IV 
cDNA kit Applied Biosystems, CA, USA I, III, IV 
RT-qPCR master mix TaqMan Fast Universal, Applied 
Biosystems, CA, USA 
I, III, IV 
Optimal Cutting 
Temperature compound for 
cryosection embedding 
O.C.T., Tissue-Tek, Sakura Finetek, 
Tokyo, Japan. 
I 
alamarBlue Invitrogen, Thermo Fischer Scientific III, IV 
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Live/dead assay Invitrogen, Thermo Fischer Scientific III, IV 
Blyscan sGAG assay Biocolor, United Kingdom IV 
Mounting medium Prolong Gold Antifade, Invitrogen, 
Thermo Fischer Scientific, MA, USA 
I, III, IV 
Equipment 
Cell analyzer  BD LSRFortessa, BD Biosciences, CA, 
USA 
III 
Thermal cycler system SimpliAmp, Applied Biosystems, CA, 
USA 
I, III, IV 
RT-qPCR system StepOne System, Applied Biosystems, 
CA, USA 
I, III, IV 
Aggrewell400 STEMCELL Technologies, Vancouver, 
Canada 
IV 
Glass slides Superfrost Plus and Polysine, Thermo 
Fischer Scientific, MA, USA 
I, III, IV 
Countess cell counter Invitrogen, Thermo Fischer Scientific, 
MA, USA 
I, III, IV 
Internal reflection 
fluorescence microscope  
TIRF, Nikon, Eclipse 80i, Tokyo, Japan I, III, IV 
Stereomicroscope Leica M205 C, Leica Microsystems 
GmbH, Wetzlar, Germany 
III, IV 
Inverted light microscope Nikon Eclipse TS100, Tokyo, Japan I, III, IV 
Confocal microscope Dragonfly 505, Andor Technology Ltd., 
Belfast, Great Britain 
III, IV 
Micro-CT SkyScan 1172, Bruker, Kontich, 
Belgium 
III, IV 
Sonicator Sonopuls HD2200, Bandelin, Berlin, 
Germany 
I, III, IV 
Microplate reader I FLUOstar OPTIMA, BMG Labtech, 
Ortenberg, Germany 
III, IV 
Microplate reader II Varioskan LUX multimode III, IV 
Sputter coater Q150TES, Quorum, Italy III, IV 
Scanning electron 
microscope 
JEOL JSM-7400F, Tokyo, Japan III, IV 
Scanning electron 
microscope 
Phenom XL Desktop SEM, Thermo 
Fischer Scientific, MA, USA 
III 
Freeze-dryer Labonco Corporation, MO, USA III, IV 
Microtome Leica, Wetzlar, Germany  I, III, IV 
Cryomicrotome Leica CM 3050S, Wetzlar, Germany I 
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3D-printer 3D-Bioplotter, EnvisionTEC Gmbh, 
Gladbeck, Germany 
III, IV 
Syringe barrels 30cc, Optimum, Nordson, OH, USA III, IV 
Printing nozzles 400 µm, Optimum, Nordson, OH, USA III, IV 
4.3. The in vivo effect of angiostatin functionalized scaffolds 
(Study I) 
4.3.1 Preparation of functionlaized collagen scaffolds  
Cells were isolated from the femur of Lewis rats in accordance with a previously 
established protocol [115] and expanded in complete medium, i.e. Alpha-minimal 
essential medium (αMEM) supplemented with 1 % antibiotics (100 U/ml penicillin and 
0.1 mg/ml streptomycin, PS) and 10 % fetal bovine serum (FBS).  
COL1 scaffolds were divided into four groups: scaffold only, scaffold functionalized 
with angiostatin, scaffold seeded with rBMSC and scaffolds functionalized with 
angiostatin and seeded with rBMSC. The groups with angiostatin were functionalized 
with 5 µg angiostatin diluted in 50 µl distilled water and pipetted onto the top of the 
scaffolds. Scaffolds with cells were seeded with 5 × 105 rBMSC. 
4.3.2 Subcutanous implantation 
The study was approved by the Norwegian Animal Research Authority. Scaffolds were 
implanted subcutaneously on the dorsum of 24 female Lewis rats (weight: 200 g, age: 
12 weeks). Subcutaneous pockets were created by blunt dissection (Figure 3). One 
scaffold from each group was implanted and the wounds closed with resorbable 
sutures. After 2 and 8 weeks, the animals were euthanized by an overdose of CO2. 










Figure 3. Image of stump dissection of subcutaneous pockets. Photo: Mohammed 
Ahmad Yassin.  
4.3.3 Molecular & histological analysis 
Samples harvested after 2 weeks were analysed with Real Time – Quantitative 
Polymerase Chain Reaction (RT-qPCR) and immunofluorescence staining for cluster 
of differentiation 31 (CD31) with quantification. Samples harvested after 2 and 8 weeks 
were analysed histologically.  
4.4 Systematic review (Study II) 
A review protocol was developed for a systematic review of the literature on scaffold-
based regeneration of TMJ structures using preclinical animal models. The aim was to 
answer the specific PICO (population, intervention, comparison, outcome) question: in 
experimental animal models, does implantation of biomaterial scaffolds loaded with 
cells and/or GFs enhance regeneration of disc or osteochondral tissues, compared with 
scaffolds alone, without cells, and/or GFs? 
Potentially relevant publications were identified by a specific search strategy of 
electronic databases (MEDLINE via PubMed, Web of Science, Google and Google 
Scholar). Published articles fulfilling the required criteria, up to and including 
November 2017, were included. Full texts were retrieved, and two authors screened the 
titles and abstracts.  
The following information was retrieved: author(s), study design, animal species and 
number of animals used, observation time(s), cell source(s), -type(s) and -numbers, 
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scaffold biomaterial(s), GF(s), control group(s), outcome(s), main findings and 
conclusions.  
The Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines were 
applied in a modified version to report quality assessment in a graded manner (‘high’, 
‘moderate’ and ‘low’ [116]. The Systematic Review Center for Laboratory Animal 
Experimentation (SYRCLE) tool  for animal studies was used to assess the risk of bias 
(RoB), graded as “high”, “low” or “unclear” [117].  
4.5 3D printing of gelatin scaffolds (Studies III & IV) 
4.5.1 Preparation of gelatin hydrogel 
A 10 % w/v hydrogel solution was prepared by mixing porcine gelatin type A (Sigma-
Aldrich) with distilled water. The hydrogel was cooled in the refrigerator at 4 °C, 
reheated to 30 °C and printed in sixteen perpendicular layers, with a shift between every 
third and fourth layer to decrease the pore size (Figure 4). After printing, the hydrogel 
was frozen, freeze-dried, and crosslinked (Figure 5).  
 
Figure 4. Schematic illustration of the printing design. 
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Figure 5. Steps in gelatin scaffold fabrication. Gelatin Type A powder (A), 10 % 
gelatin solution (B), 3D printing (C), 3D printed gelatin scaffold (D), freeze drying 
(E) and final scaffold (F). 
Genipin (Study III) 
Genipin (Wako) was dissolved in distilled water to a 1 % w/v solution under constant 
magnetic stirring in a 50 ml tube (40 ºC, 3 h). Scaffolds were crosslinked in 1 ml 
crosslinking solution for 48 h at room temperature. After crosslinking, the scaffolds 
were rinsed with PBS, frozen and freeze-dried (48 h, -52 °C, 0.014 mbar).    
Dehydrothermal (Study IV) 
In Study IV, freeze-dried scaffolds were shipped to collaborators at The Institute of 
Science and Technology for Ceramics (ISTEC, Milan, Italy). The scaffolds were 
subjected to heat treatment in an oven at 160 ºC under vacuum (48 h, 0.01 mbar).  
Ribose (Study IV) 
A 25 mM ribose solution was prepared by dissolving ribose in a solution of ethanol 
and phosphate buffered saline (PBS) at a ratio of 70/30 [118]. Freeze-dried samples 
were submerged in the solution in order to achieve a 1:1 ratio of gelatin and ribose, 
maintained at 37 °C for 5 days with gentle shaking. After ribose crosslinking, the 
scaffolds were freeze-dried with a cycle including two heating ramps, the first of 5 °C/h 
from -40 °C to -5 °C and the second of 3 °C/h to 20 °C for three days under vacuum 
conditions (0.086 mbar). 
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DHT + Ribose (Study IV) 
Scaffolds were first crosslinked by DHT, and subsequently crosslinked by ribose as 
described above.  
4.5.2 Degree of crosslinking (Study IV) 
To determine the degree of crosslinking, the concentration of free primary amines (-
NH2) or carboxylic groups (-COOH) in non-crosslinked and crosslinked scaffolds was 
measured by a 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS) assay, according to a 
previously reported protocol [119]. One ml of a 4 % (w/v) NaHCO3 solution was added 
to each 5 mg of sample. Then, 1 ml of a freshly prepared solution of 0.5 % (w/v) TNBS 
was added after 30 min. The reaction mixture was heated at 40 °C for 2 h, before 3 ml 
of 6M HCl solution were added (60 °C, 90 min) to terminate the reaction. The reaction 
mixture was first diluted 1:1 with distilled water, before being cooled to room 
temperature. The absorbance at 415 nm was measured using a UV–visible 
spectrophotometer NanoDrop One C (Thermo Fisher Scientific). Blank control 
samples were prepared with the same procedure without scaffolds. The absorbance of 
the blank samples was then subtracted from each sample’s absorbance. Measurements 
of all samples were run in triplicate. 
The crosslinking percentage (CD) was evaluated using the following equation: 
 
𝐶𝐷 (%) = (1 −
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒𝑠
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑛𝑜𝑛 − 𝑐𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑒𝑑 𝑐𝑜𝑛𝑡𝑟𝑜𝑙𝑠
 ) × 100 
4.6 Structural characterization (Studies III & IV) 
4.6.1 Micro computed tomography  
Micro computed tomography (µCT, SkyScan) was used to evaluate the open porosity, 
surface area (mm2) and surface volume (mm3) of the scaffolds. For 3D reconstruction 
of the scaffolds, NRECON RECONSTRUCTIONVR CT software (SkyScan) was 
used.  
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4.6.2 Scanning electron microscopy  
Crosslinked scaffolds were vacuum dried, sputter-coated with platinum and imaged 
(5 kV) using a scanning electron microscope (SEM, Jeol).  
4.6.3 Swelling  
Freeze-dried scaffolds were initially weighed in the dry state (W0), before immersion 
in 10 ml of PBS at 37 ºC for 48 h (Study IV) and 72 h (Study III). At defined timepoints, 
swollen scaffolds were weighed (W1). The liquid uptake was calculated according to 




 ×  100 
4.6.4 Change in mass  
For dynamic stability testing (Study III), freeze-dried scaffolds were weighed (W0) 
before immersion in 10 ml of PBS at room temperature on a mechanical shaker. The 
PBS was changed after each timepoint (1, 3, 7, 14, 21 and 28 days). Samples were 
freeze-dried (48 h) and weighed (W1, W3…W28), before re-immersion in PBS until the 
next timepoint. Mass loss was calculated using the following formula:  
𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑚𝑎𝑠𝑠 (%) =
(𝑊0 − 𝑊1)
𝑊0
 × 100 
For static stability testing (Studies III and IV), scaffolds were kept in 1 ml of complete 
medium, i.e. Alfa-minimal essential medium (αMEM) supplemented with 1 % 
antibiotics and 10 % FBS. The scaffolds were incubated (37 ºC in 5 % CO2) for 7, 14, 
21 (Study III) and 35 days (Study IV). The medium was changed twice a week. Three 
samples from each timepoint were imaged in a microscope (Leica M205 C) and 
freeze-dried for 48 h before weighing and imaging. The same formula as described 
above was used to calculate the percentage of mass loss.  
For stability testing, scaffolds were weighed after freeze-drying (W0) and immersed 
in 1 ml of complete medium in 24-well plates. The scaffolds were incubated (37 ºC 
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in 5 % CO2) for 7, 14 and 21 days. The medium was changed twice a week. At the 
defined timepoints, samples were freeze-dried (48 h) and weighed (e.g. W1). Loss of 
mass was calculated by the same formula.  
4.6.5  Enzymatic degradation (Study IV) 
The stability of crosslinked gelatin scaffolds was evaluated by an in vitro enzymatic 
degradation test, as reported previously [118]. Briefly, dry scaffolds were incubated in 
1 ml 0.1M Tris-HCl (pH 7.4) containing 50 U/ml bacterial collagenase (Clostridium 
histolyticum, Type 1, Sigma-Aldrich), at 37 °C. The time required for complete 
digestion of non-crosslinked gelatin was 2 h. The scaffolds (n = 3 from each group) 
were freeze-dried, and their degradation was determined by UV-vis Spectrophotometer 
NanoDrop One C (Thermo Fisher Scientific) (see Eq.1). The percentage degradation 
of the samples was calculated with the non-crosslinked collagen considered to be 100 
% degraded.  
Eq.1     𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 (%) =
𝐴𝑓
𝐴𝑐𝑡𝑟
 × 100 
 Af = absorbance after 2 h in collagenase solution of sample. 
 Actr = absorbance after 2 h in collagenase solution of non-crosslinked sample. 
4.7 Mechanical testing (Studies III & IV) 
Cylindrical scaffolds 10 mm in diameter of and 8 mm in height, with the same internal 
design, were printed and crosslinked, as previously described. Young’s Modulus of the 
different crosslinked scaffolds was calculated from the linear part of the stress-strain 
curve. Creep tests (Study IV) were carried out at 0.03 MPa. After an isothermal period 
of 5 min at 37 °C, they were subjected to a defined stress for 15 min, before being left 
without any stress for 15 min. 
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4.8 Scaffold sterilization (Studies III & IV) 
3D printed gelatin scaffolds fabricated for Study III were sterilized by 70 % ethanol for 
30 min, followed by 2 h UV-light exposure and air-drying in a laminar flow hood. The 
scaffolds were washed with PBS to remove remnants of ethanol. For Study IV, 
scaffolds were sterilized by gamma irradiation and sterile packaged before use. All 
scaffolds were pre-wetted in complete medium and incubated for 24 h before seeding. 
4.9 Cell culture 
4.9.1 Cell isolation  
Rat BMSC (Studies I & IV) 
Ethical approval for obtaining rat cells was granted from the Norwegian Animal 
Research Authority. Cells were harvested and isolated in accordance with established 
protocols [115].  
Human BMSC (Study III) 
Ethical approval for obtaining human bone marrow was granted by the Regional 
Ethical Committees for Medical and Health Research Ethics. Parental informed 
consent was obtained according to ethical guidelines. The cells were isolated as 
previously described [54]. Aspirates were obtained from the iliac crest of two donors 
(7 and 12 years old) undergoing iliac crest surgery for cleft lip and palate 
reconstruction.   
Cells for all experiments were cultured in complete medium (i.e. alpha minimum 
essential medium, containing 1 % antibiotics and 10 % fetal bovine serum); incubation 
was at 37 °C in 5 % CO2, with changes of medium every third day.  
4.9.2 In vitro tri-lineage differentiation and evaluation (Study III) 
Multi-lineage differentiation was conducted according to previously described 
methods [54]. Chondrogenic and adipogenic differentiation were conducted in defined 
medium (Gibco) and osteogenic differentiation in complete medium supplemented 
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with 0.05 mM L-ascorbic acid 2-phosphate, 10 nM dexamethasone and 10 mM β 
glycerophosphate (Sigma-Aldrich). Briefly, adipogenic and osteogenic differentiation 
was investigated by culturing 7 × 103 and 3 × 103 hBMSC in 12-well plates for 14 and 
21 days, respectively. The cells were washed with PBS and induced after 24 h by 
adding adipogenic and osteogenic medium. Chondrogenic differentiation was 
performed in 15 ml tubes with 1 ml of 5 × 105 cells in suspension, centrifuged and 
cultured as pellets for 28 days in chondrogenic medium. Complete medium served as 
the control for all cultures. Oil red O, Alizarin red and Alcian blue (Sigma-Aldrich) 
stainings were used to confirm lipid vesicles, calcium deposition and proteoglycan 
matrix for adipogenic, osteogenic and chondrogenic differentiation, respectively.  
4.9.3 Indirect cytotoxicity (Study III) 
The cytotoxicity of the crosslinker concentration was investigated by culturing hBMSC 
in genipin-extraction medium and comparing with control medium. The viability was 
evaluated using live/dead (Invitrogen) and alamarBlue (Invitrogen) assays after one 
and three days.  
4.9.4 Formation of pellets and spheres (Study III) 
Pellets were formed by suspending 3 × 105 hBMSC (passage 5) per ml of chondrogenic 
medium and distributed as 1 ml per 15 ml tube. Cell suspension was centrifuged (1200 
rpm for 5 min) and incubated with the cap loosened to ensure gas exchange. After 24 
h a spherical cell pellet was evident at the bottom of the tube.  
Spheres were formed by using Aggrewell-400 microwell culture plates according to 
the manufacturer’s instructions. Each well contained 1200 microwells, and 1.2 × 106 
hBMSC per well were seeded, suspended in chondrogenic medium. The plate was 
centrifuged and 1200 spheres (1000 cells/sphere) were formed after 24 h of incubation 
(Figure 6). The spheres were cultured in the microwells for the entire culture period of 
21 days.  
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Pellets served as a control for chondrogenic differentiation and spheres and scaffolds 
were compared to pellets with reference to gene expression, immunofluorescence and 
Alcian blue staining. 
 
Figure 6. Illustration of microwell culture plates for spheres formation. Spheres 
imaged after 24 h (scale bar 60 µm). 
4.9.5 Cell seeding of scaffolds (Studies I, III & IV) 
Medium from the pre-wetting was discarded before cells were seeded using a 70 µl cell 
suspension. The cell suspension was distributed drop wise onto the top of the scaffolds. 
Cells were allowed to attach for 1 h before additional medium (430 µl) was added to 
the wells. The medium was changed every third day. 
4.9.6 Cell attachment and seeding efficiency (Studies III & IV) 
The morphology, density and attachment were assessed 4 h after seeding the scaffolds. 
Samples were fixed in 3 % GTA, vacuum dried, sputter-coated with platinum and 
imaged (5 kV) by SEM (Jeol). Seeding efficiency was calculated using a DNA-based 
cell proliferation assay (PicoGreen). The fluorescence units (FU) of the cells attached 
to the scaffolds and the cells remaining in the wells after seeding were compared to 2D 
controls seeded with the same cell number. Blank controls (empty wells) and scaffolds 
without cells were subtracted from the FU before the calculations. Cell seeding 
efficiency, based either on the cells on the scaffold (sc) (Study III) or cells remaining 
in the wells (w) (Study IV), was calculated according to the following formula:  
𝐶𝑒𝑙𝑙 𝑠𝑒𝑒𝑑𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦𝑠𝑐  (%) =
(FUsc − FUblank)
FU2D
 ×  100 
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𝐶𝑒𝑙𝑙 𝑠𝑒𝑒𝑑𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦𝑤  (%) = 100% − [
(FUsc − FUblank)
FU2D
 ×  100] 
 
4.9.7 Cell distribution (Study III) 
To investigate the distribution of cells on the scaffolds, they were cultured for 1 and 4 
days in basal medium, fixed in 10 % formalin for 15 min, washed with PBS and 
permeabilized with 0.1 % Triton-X (in PBS) for 10 min, then incubated with Alexa 
Fluor 488 Phalloidin (Thermo Fischer Scientific) diluted in PBS (1:50, 40 min in the 
dark). Cell nuclei were stained with 4′,6-Diamidino-2-phenylindole dihydrochloride 
(DAPI) in PBS, 1:3000, for 10 min in the dark. After washing with PBS, the scaffolds 
were imaged using a 3D confocal microscope (Dragonfly 505). 
4.9.8 Cell viability (Studies III &IV) 
The cell viability on the seeded scaffolds was evaluated after 1 and 4 days using 
live/dead staining (Invitrogen) according to the manufacturer’s protocol. Briefly, 1.5 
µl green staining was mixed with 5 ml PBS, before adding 1.5 µl red staining. 
Medium was discarded from the wells and the scaffolds were washed with PBS. After 
45 min incubation in the dark, the scaffolds were examined in a fluorescence 
microscope (Nikon Eclipse 80i).  
4.9.9 Cell proliferation (Studies III & IV) 
Proliferation of BMSC on scaffolds was investigated by DNA quantification 
(PicoGreen) after culture in basal medium (2 × 105 cells) and in differentiation medium 
(1.2 × 106 cells) for seven days. FLUOstar OPTIMA (BMG Labtech) was used for plate 
reading of the fluorescence units (FU).  
4.9.10 RT-qPCR (Studies I, III & IV) 
RNA was extracted following the protocol from Maxwell (Promega) and measured 
using NanoDrop 1000 Spectrophotometer (Thermo Fischer Scientific). A standardized 
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amount (ng) of RNA was used for cDNA synthesis using High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) and SimpliAmp Thermal Cycler 
(Applied Biosystems). For PCR, TaqMan Fast Universal PCR Master Mix (Applied 
Biosystems) and StepOne RT-PCR System (Applied Biosystems) were used for gene 
expression detection. Glutaraldehyde 3-phosphate dehydrogenase (GADPH) was used 
as an endogenous control. Table 2 presents the genes and their roles.  






Interleukin 1 alpha Active in cartilage degeneration [120]. 
IL1B  
(I) 
Interleukin 1 beta Activates and recruits macrophages. Active in 
cartilage degeneration [120].  
SOX9 
(I, III, IV) 
SRY-box 9 Main chondrogenic transcription factor [62] 
ACAN 
(I, III, IV) 
Aggrecan Cartilage-specific core protein. Major 
structural component of cartilage. Regulated 
by SOX9 [64].  
COL1 
(I, III, IV) 
Collagen type 1 Main collagen component of fibrocartilage 
[7].  
COL2 
(I, III, IV) 
Collagen type 2 Main collagen component of hyaline 





Collagen type 3 Fibrocartilage marker controlling fibril 
diameter of COL1 [121] 
COL10  
(III, IV) 
Collagen type 10 Hypertrophy marker expressed by terminal 






Stimulates angiogenesis and endothelial cell 






A major constituent of blood vessel forming 
cells, endothelial cells [43].  
4.9.11 Histology (Studies I, III & IV) 
For histological analysis in Study I, the harvested tissue was embedded in Optimal 
Cutting Temperature compound (Tissue-Tek). Cryosections of 5 μm thickness were 
made and mounted on glass slides. Samples were stained for hematoxylin and eosin 
(H&E) and Masson’s Trichrome (MTC) and blindly described by a pathologist.  
4.9.12 Immunofluorescence staining (Studies I & III) 
In Study I, samples, after 2 weeks implantation were stained with immunofluorescence 
for CD31 and quantified. Cryosections were fixed using ice cold acetone for 10 min, 
before blocking for 1 h in 10 % normal goat serum (NGS in PBS). Primary antibody, 
mouse anti-rat (BD Bioscience), was incubated (1:50 in 10 % blocking buffer) 
overnight at 4 °C. Secondary antibody (Santa Cruz, sc-2092) was incubated (1:200 in 
10 % blocking buffer) for 2 h at room temperature, in the dark.  Sections were 
quantified for CD31+ region of interest (ROI) divided by total ROI, using a TIRF 
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microscope (Nikon Eclipse 80i) and digital software (NIS-Elements Advanced 
Research Software).  
In Study III, scaffolds, spheres and pellets were fixed in 10 % formalin for 15 min and 
washed with PBS. Sections were mounted on polysine-treated glass slides to ensure 
adequate adhesion. Spheres and pellets were treated with 0.1 % Triton-X for 30 min 
and blocked in 10 % NGS for 1 h, both at room temperature in 1.5 ml tubes. Primary 
antibody for SOX9 (Abcam 185966, rabbit monoclonal antibody, 1:200 diluted in 10 
% NGS) and COL1 (Abcam 34710, rabbit polyclonal antibody 1:500 in 10 % NGS) 
were incubated overnight at 4 °C. After washing with PBS, SOX9 and COL1 were 
conjugated with secondary antibody Alexa Fluor 488 (goat anti-rabbit, ThermoFischer 
Scientific) and incubated (1:200, SOX9 and 1:800, COL1) for 2 h at room temperature.  
All the immunofluorescence stainings were combined with DAPI (1:3000, 10 min in 
the dark) to stain the nuclei. Spheres and pellets were imaged using a 3D confocal 
microscope (Dragonfly 505). Sections of scaffolds were imaged using a TIRF-
microscope (Nikon Eclipse 80i).  
4.9.13 Glycosaminoglycan assay (Study IV) 
Sulphated glycosaminoglycan (sGAG) assay (Blyscan) was conducted according to the 
manufacturer’s protocol. Briefly, samples were snap frozen after 21 days of culture and 
stored at -80 °C. Samples were thawed and transferred to 1.5 ml tubes with 1 ml Papain 
Extraction Reagent and placed in a shaking water bath (65 °C, 60 rpm) for 3 h of 
digestion. Samples were centrifuged and supernatant collected. Of the supernatants, 
100 µl were pipetted into new 1.5 ml tubes, before 1 ml Dye reagent was added and 
incubated in room temperature for 30 min on a mechanical shaker (60 rpm). This 
resulted in the formation of a sGAG-dye complex. The tubes were then centrifuged. 
The sGAG-dye complex formed a pellet, and the supernatant was removed carefully to 
avoid disturbing the complex. To dissolve the complex, 500 µl Dissociation Reagent 
was added and vortexed for 10 min. For measurements, 200 µl of each sample were 
pipetted into individual wells of a 96-well plate. Plate readings were performed using 
Varioskan (Thermo Fischer) measuring the absorbance with a wavelength of 656 nm.  
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4.10 Statistical analysis (Studies I, III & IV) 
In Study I, a Shapiro-Wilk test on the residual from the univariate one-way analysis of 
variance (ANOVA) was used to test the normality. For the non-normally distributed 
data (COL1), a non-parametric test (Mann-Whitney U test) was applied. To determine 
intergroup statistical significances, a Tukey’s post-hoc comparison of the mean using 
SPSS Statistic 25 (IBM, Armonk. NY, USA) was performed. In Studies III and IV, 
ΔCt-values were used in a mixed-effects model with regression to calculate the 
difference between the timepoint within the groups. One-way ANOVA was used to 
detect intergroup statistical differences at the same timepoints, using STATA (version 
16, StataCorp, College Station, TX, USA). The results were presented as box plots with 
median and 95 % confidence interval. Inter- and intragroup statistical significance was 
set to p-values ≤ 0.05. All quantitative data are presented as mean ± standard deviation 
(SD), unless stated otherwise. Graphs and plots were made using GraphPad Prism 
(version 7.04).  
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5.  Summary of main results and general discussion 
Strategies for regeneration of lost or damaged TMJ cartilage can be classified as 
scaffold-free and scaffold-based [30]. Scaffold-free approaches involve in vitro self-
assembly and self-organization processes, which are intended to simulate in vivo 
development of cartilage by the cells and to replicate the native morphology [123]. 
These approaches rely on a high density and proximity of the cells to facilitate cell-to-
cell communications and stimulation of ECM-secretion [123]. Potentially, this 
produces biochemically mature and mechanically robust structures pre-implantation, 
which integrate more readily [83]. In orthopaedics, harvesting CC before in vitro self-
assembling and re-implantation in articular cartilage defects (i.e. ACI) is an established 
method [124]. There are however, few such methods for TMJ regeneration. A 
successful scaffold-free approach by injection of nasal CC for regeneration of TMJ 
condyle resorption has been reported [40]. As this is a minimally invasive method, both 
injection and ACI risk uneven distribution and leakage of cells. The method is therefore 
limited to minor defects [125]. Another example of a scaffold-free approach is the use 
of aggregated cell cultures, e.g. pellets, regarded as the standard method for 
chondrogenic differentiation of MSC in vitro [67]. However, massive cell numbers are 
required and output is low, because only one pellet is cultured per tube. More recently, 
smaller-sized aggregates, i.e. spheres, have been reported to enhance the stemness, 
survival and differentiation potential of MSC [73]. This method allows for high-
throughput manufacturing of uniform size-controlled spheres facilitated by microwell 
platforms [77].  
While scaffold-free approaches are promising, especially for regenerating minor 
defects [42], for larger defects scaffold-based strategies provide greater structural 
support. Depending on the source material(s), scaffolds can be tailored to accommodate 
regional differences in porosity and stiffness and can be functionalized with cells 
and/or biomolecules [30]. Scaffolds serve as carriers for cell-transplantation and offer 
a temporary 3D framework on which cells can form a new matrix, and also provide a 
template for endogenous cell recruitment [123].  
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Ideally, the rate of scaffold degradation should match the rate of neotissue formation, 
without provoking uncontrolled inflammatory reactions.  The mechanical properties of 
the scaffold should be equal to the native structures it is intended to replace [30]. These 
stringent requirements underline the importance of appropriate biomaterial(s) 
selection. Polymers, both natural and synthetic, are frequently used for CTE [86]. 
While natural polymers, e.g. collagen and gelatin are generally biocompatible and 
biodegradable and simulate native ECM more closely than synthetics, they often lack 
the durability of the native tissues. Alternatively, synthetic polymers can be more 
readily tailored with respect to degradation rates and mechanical properties, which are 
important properties in case of  reconstruction of complex structures with regional 
variations [87]. However, they tend to be hydrophobic and their acidic degradation 
products can provoke uncontrolled inflammatory responses [86].  
COL1 is the main component of fibrocartilage [7]. It exhibits excellent 
biocompatibility, biodegradability, hydrophilicity and cell attachment properties and is  
widely used as a scaffold biomaterial for CTE [91].  Gelatin also exhibits the above 
properties, but with less antigenicity and at a lower cost [97]. Moreover, gelatin is 
thermo-reversible, with superior hydrogel-forming properties to collagen. Gelatin can 
therefore be used for 3D printing. However, without proper crosslinking, the natural 
polymers exhibit poor stability and mechanical properties.  
The main focus of this thesis was to explore scaffold-based approaches to regeneration 
of the cartilaginous structures of the TMJ, using natural polymers and BMSC. In Study 
III, pellets and spheres were included for comparison of scaffold-free alternatives for 
TMJ regeneration.  
 The in vivo effect of angiostatin functionalized collagen 
(Study I) 
There are few studies of the role of vascular inhibition in regeneration of naturally 
avascular structures [81]. An untoward consequence of vascularization of cartilaginous 
structures could be mineralization, such as endochondral ossification, which might 
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endanger the stability of the implants [43]. Study I was therefore undertaken in order 
to investigate the vascular inhibiting effects of angiostatin and its potential for 
chondrogenic differentiation of MSC cultured on collagen scaffolds, in an ectopic rat 
model. 
At the gene level, the expression of VEGF (Figure 8A) and PECAM1 (Figure 8B) was 
downregulated in the angiostatin groups 2 weeks after implantation. This was 
confirmed by immunofluorescence staining and quantification of CD31 positive areas 
(Figure 7). VEGF is associated with CC hypertrophy during endochondral ossification 
[126]. Moreover, VEGF-inhibition has been proposed as a promising target molecule 
for treatment of chronic closed lock [127]. The results of Study I are in accordance with 
those of  Centola et al., reporting similar lower CD31+ cell infiltration using fibrin-
hyaluronan scaffolds, functionalized with bevacizumab, a VEGF-inhibitor, seeded 
with nasal chondrocytes [43]. 
Vascular levels are closely associated with inflammation [128]. After two weeks in 
vivo, angiostatin downregulated the gene expression of the inflammatory markers IL1A 
(Figure 8C) and IL1B. Elevated levels of these markers have been reported in patients 
with degenerative TMJ diseases [129]. Therefore, functionalization of implanted 
scaffolds with factors which could decrease the levels of inflammatory cytokines may 
be promising means of re-establishing homeostasis of the TMJ and initiating a 
regenerative process.  
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Figure 7. Immunofluorescence staining for CD31 (red signal) after 2 weeks’ 
implantation. M/-, scaffolds loaded with MSC; M/A, scaffolds functionalized with 
angiostatin and loaded with MSC. 
The potential of Angiostatin to promote chondrogenic differentiation of MSC-
seeded collagen scaffolds in vivo 
SOX9 is an essential transcription factor for chondrogenesis [130].  The fact that 
heterozygous mutations in SOX9 can lead to severe chondrodysplasias [131], 
highlights its importance. It regulates the expression of both ACAN [64] and COL2 
[65], both important components of cartilage. ACAN is a core protein vital for GAG 
formation, which contributes to the mechanical toughness of cartilage [66]. Although 
angiostatin-functionalized scaffolds supported expression of cartilage-specific genes, 
the levels were downregulated (non-significantly). The decreased levels of ACAN 
(Figure 8E) and COL2 can be linked to the downregulation of SOX9 (Figure 8D), but 
the fibrocartilage-related gene COL1 was also influenced (Figure 8F). IL-1 is reported 
to decrease the levels of SOX9 in CC [132], which was the same effect observed for 
angiostatin on MSC. 
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Figure 8. A selection of gene markers for vascularization (A-B), inflammation (C) and 
fibrocartilage specific genes (D-F) for Study I. -/-, scaffold only; -/A, scaffolds 
functionalized with angiostatin; M/-, scaffolds loaded with MSC; M/A, scaffolds 
functionalized with angiostatin and loaded with MSC; *, p < 0.05; **, p < 0.01. 
Histologic examination revealed that implants from all groups were surrounded by a 
thin fibrous capsule, supporting biocompatibility of the scaffold material (Figure 9). 
Multinucleated giant cells (MNGC) are commonly observed with engulfed degradation 
products [133] and this was apparent in all groups. The blinded, descriptive histological 
evaluation by a pathologist, revealed a higher presence in the angiostatin groups. The 
differences had decreased after 8 weeks, indicating complete degradation or release of 
angiostatin. The increase of MNGC in the angiostatin-groups may be related to the use 
of a human recombinant type and is not in agreement with the findings of Centola et 
al. of an inhibitory effect of the monoclonal VEGF-antibody, bevacizumab, on 
















Figure 9. A selection of histological images (Haematoxylin and eosin staining) after 
2- and 8-weeks implantation. Fibrous capsule (red arrows), scaffold pores (blue 
arrows), multinucleated giant cells (green arrows), mononuclear inflammatory cells 
(yellow asterix). M/-, scaffolds loaded with MSC; M/A, scaffolds functionalized with 
angiostatin and loaded with MSC. 
While all groups demonstrated new collagen matrix formation (Figure 9), the group 
with scaffolds functionalized with angiostatin and seeded with MSC (‘M/A’) revealed 
the greatest, after 8 weeks. The contribution of the implanted MSC to matrix formation 
was expected. However, the histology does not correspond with the gene levels after 2 
weeks, as the control group with scaffold only (‘-/-’), had the highest expression of 
COL1, COL2 and COL3. This illustrates the difficulty of selecting timepoints and the 
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importance of histological evaluation of the newly formed tissues. Despite matrix 
formation in all groups, there was no evidence of cartilage. This can be explained by 
the use of undifferentiated MSC in an ectopic site, in the absence of endogenous signals 
or mechanical stimulation [134]. Others have successfully engineered ectopic 
cartilaginous structures, using CC and preconditioning scaffolds in vitro with anti-
angiogenic factors [43]. By seeding the scaffolds with mature cells like CC, with the 
capacity to secrete cartilaginous matrix, ectopic cartilage formation using angiostatin 
might be possible. As functionalization of scaffolds with angiostatin to supress 
vascularization was not sufficient, incorporation of inductive GFs in the scaffold [87], 
could be a strategy to induce MSC in vivo.  
Similar strategies, with different factors have been reported for articular CTE. Sun et 
al.  [80] used non-viral transfection of MSC with endostatin seeded on collagen 
scaffolds. MSC were successfully transfected and produced potentially therapeutic 
levels of endostatin in vitro. Jeng et al.  [81] used endostatin-plasmid-supplemented 
collagen scaffolds seeded with MSC and CC for cartilage repair. In contrast to 
angiostatin’s effect on MSC in vivo, endostatin-supplemented collagen scaffolds did 
not prevent chondrogenesis of co-cultured cells in vitro. The impact of combining CC 
with BMSC has been demonstrated clinically in a phase-I trial using allogenic BMSC 
and autologous CC (with pericellular matrix) in a 90:10 or 80:20 ratio, respectively. 
The ratio ws dependent on the amount of available CC for harvest at the site of injury 
and the mix was combined with fibrin-glue to adhere to focal articular cartilage defects 
in 10 patients [58]. After 12 months there were no signs of allogenic cells in the defect 
and the authors suggested that the paracrine effect of MSC stimulated the structural 
and functional restoration of the cartilage.  
In Study I, the dose and release of angiostatin were not optimized, and this must be 
considered a limitation that may have influenced the fate of the implanted MSC. 
Moreover, the cell seeding density was in the lower range considered optimal for in 
vitro CTE and fibrochondrogenesis [135]. Failure to achieve mature cartilage 
formation in this study and the observed lack of established methods for TMJ cartilage 
regeneration reinforced the need for a thorough literature review of established 
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knowledge within the field of in vivo TMJ TE.  A systematic review was therefore 
undertaken to assess the limitations and potential of scaffold-based cartilage 
regeneration, with special reference to the scaffold material, shape, cell types and 
animal models.   
 Systematic review (Study II) 
Systematic reviews and meta-analysis can be helpful in providing an overview of a 
specific topic or field, and for planning future studies. Animal experiments need to be 
well designed, conducted and analyzed in order to provide reliable results [136]. 
Systematic reviews can improve methodology and provide valuable information about 
previous work and experience. In contrast to narrative reviews, which include studies 
based on expert opinions, a systematic review is intended to answer a focused research 
question by including studies which meet pre-defined criteria [136]. Thus, systematic 
reviews are more objective and comprehensive with respect to the use of sources and 
databases for inclusion of studies. The impact of summarizing research findings with a 
high level of evidence and well-designed interventional studies is high, and systematic 
reviews and meta-analysis are therefore generally considered to be the highest level of 
scientific evidence.  
In conclusion, the results of the systematic review showed that strategies including 
implantation of biomaterials with cells and/or GFs, were superior to biomaterials alone. 
Implantation of a scaffold only was superior to an empty defect or no implant. Further, 
differentiated MSC were superior to undifferentiated cells. However, the included 
studies lacked consistency: more standardized methods and quantitative reporting of 
data would facilitate comparison and meta-analysis of the results.  
5.2.1 Systematic review of animal models 
The systematic review included 30 studies of both small (n = 25) and large (n = 5) 
animal models. The included studies, published in the period 1994-2017, comprised 
both ectopic (i.e. subcutaneous) and orthotopic models in five different species (Table 
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). The sample sizes varied from 2-60, and the observation times from two weeks to 12 
months.  
Table 3. Number of studies of the different models and species  
  Mice Rabbits Dogs Goats Sheep Total 
Ectopic 
 
SM 1     12 
Disc 3     
Condyle 8     
Orthotopic 
 
Disc  6 2   18 
Condyle  7 
5 
 2 1 
SM, synovial membrane. 
Small animals, like mice, that often constitute a starting point for proof of principle 
studies [112], have advantages such as lower costs and easier housing and handling 
[113]. The potential to control the genetic background results in less variation and 
reduces the number of animals needed to obtain statistically valid data [137]. All 
ectopic models included subcutaneous implantation in mice, in experiments into 
regeneration of TMJ disc, condyle or synovial membrane. Cell-seeded scaffolds (most 
commonly BMSC) demonstrated regeneration outcomes superior to cell-free scaffolds, 
and differentiated cells were better than undifferentiated cells. The latter conclusion is 
transferable to Study I, in which undifferentiated BMSC did not form ectopic cartilage 
matrix. However, the heterogeneity of the studies made comparison of the results 
difficult. Rodent size limits feasibility for orthotopic models, because of the physical 
difficulty of the surgical approach [138, 139]. It is of interest to note however, that 
investigators at Massachusetts General Hospital (MGH) recently published a thorough 
guide to mouse TMJ anatomy and surgical approach for orthotopic TMJ regeneration 
[140]. Despite the disadvantage of size, this well-described protocol is a valuable guide 
to the planning and conduct of future orthotopic in vivo studies in rodents.  
Rabbit was the most frequently reported species for orthotopic models. Rabbits have 
many of the advantages of rodents, but their size allows for easier surgical access. Two 
included studies reported disc defect models, where surgical perforations were created, 
and scaffolds implanted. This model is analogous to the critical-sized defect models 
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often used in BTE. It is easier to secure the implant in site, compared to a total disc 
replacement model, which is more susceptible to displacement [88]. 
It should be noted that spontaneous healing of defects in orthopedic rabbit models has 
been reported [141] and evidence of regeneration should therefore be interpreted with 
caution. However, the regeneration could be controlled for by including group(s) with 
an empty defect/no implant for base-line comparison. Other disadvantages of rabbits 
are related to the anatomy, movement and loading, which differ considerably from the 
human TMJ [141], which makes it less than ideal for translational purposes.  
Although no animal model can fully replicate the clinical setting, the results from large 
animal models are considered to be more readily translational with respect to 
therapeutic efficacy [137]. Dogs, sheep, and goats were all included in the review. 
However, they all have advantages and disadvantages. Dogs are carnivores, with higher 
loading on the TMJ than sheep and goats (herbivores) and pigs (omnivores) [114]. With 
respect to jaw movements, the TMJ in dogs mainly rotates, while sheep and goats have 
primarily translational jaw movements [114]. Pigs have both rotational and 
translational jaw movements, and are reported to be the species with TMJ function, 
anatomy and morphology most closely resembling that of humans [142]. However, in 
addition to the general drawbacks of large animal models, such as costs and handling 
difficulty, farm pigs exhibit inferior growth of the zygomatic arch, which obstructs 
lateral preauricular access to the TMJ [142]. Combined with the further disadvantage 
of continuous growth until 18 months [114], this might explain the absence of pig 
models from the review.  
A recent publication used a self-assembly scaffold-free strategy using allogenic CC for 
regeneration of a TMJ disc defect in a minipig model [42]. Although minipigs have a 
slower growth rate than farm pigs, they pose the same challenge of inferior growth of 
the zygomatic arch, hindering preauricular surgical access [142]. Therefore, a 
posterolateral approach was used to create a defect resembling the clinical condition of 
early-stage disc-thinning. In a preliminary study of a disc defect model, implant 
fixation had failed, highlighting the difficulty of adequate anchorage of an implant 
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which is subject to rotational and translational movements. Despite the need for a 
further surgical intervention to harvest CC and the associated risk of  donor-site 
morbidity, the authors recommended the costal ribs as a clinically attractive source of 
CC, based on their abundant availability and their potential to produce a robust ECM 
with high mechanical integrity [143].  
5.2.2 Cells and biomaterials in the systematic review 
Several different cell types were reported. Adult MSC were reported in 12 studies, with 
BMSC most frequent (n = 12). CC were reported in six studies, either alone or in 
combination with BMSC, fibroblasts or osteoblasts for ectopic condyle regeneration. 
Adult MSC from other sources such as adipose tissue, synovial tissue and condylar 
fibrocartilage, were also described. Whole bone marrow and fibroblast-like 
synoviocytes were less frequently reported. The ideal cell source for TMJ TE remains 
unclear. However, BMSC are attractive candidates. They are: more readily available 
than CC, exhibit minimal donor-site morbidity, are well-characterized and are reported 
to have greater chondrogenic differentiation potential than ASC [54]. 
Of the various scaffold biomaterials reported (Table 4), natural polymers (n = 17) were 
the most frequent, followed by synthetic biomaterials (n = 10). The remaining studies 
used a combination of natural and synthetic biomaterials (n = 3). Most of the scaffolds 
were either commercially available products or fabricated by traditional methods, e.g. 
freeze-drying, moulding or salt-leaching. Only a minority were fabricated by 3D 
printing technology. The first reported study was from 2005, by Schek et al.  [144] 
using indirect solid free-form fabrication to create a cylindrical mould for a condyle 
scaffold. The bone-phase scaffold was created by casting hydroxyapatite (HA) 
followed by sintering, and the polymeric scaffold (PLA) was created by salt-leaching 
in the same mould. The bi-phasic scaffold was bonded by solubilized PLA. The 
ceramic scaffold was seeded with bone morphogenetic protein 7 (BMP-7) gene 
transfected fibroblasts and the polymeric scaffold with CC. Ectopic implantation 
successfully resulted in bone and cartilage formation in the bi-phasic scaffold with a 
mineralized interface. This is another example of the importance of using differentiated 
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cells in an ectopic site. Such a result is difficult to achieve with a scaffold-free 
approach.  
Table 4. Overview of scaffold biomaterial(s) and application according to year of 
publication of the included studies.  
Year Application Material(s); GFs Reference  
1994 Disc PLA+PGA [145]  
1996 Condyle defect Gelatin + (Fib/Throm 1:1) [146]  
2000 Condyle defect Collagen [147]  
2001 Condyle PLA+PGA+Pluronic+CaSO4 [148] 
 
2002 Condyle defect Collagen; rhBMP-2  [149]  
2002 Condyle Coral, natural [150]  
2003 Condylectomy PLA+PGA+Gelatin; rhBMP-2 [151]  
2003 Condyle PEDGA [152]  
2004 Disc defect Collagen [153]  
2005 Disc defect Collagen/ subdermal grafts [154]  
2005 Condyle PEDGA [155]  
2005 Condyle PLA+HA [144]  
2007 Condyle defect Collagen; FGF-2 [156]  
2010 Condylectomy UB-ECM+Collagen [157]  
2011 OC defect Pluronic F-127 [158]  
2011 OC defect PLGA [159]  
2011 Condyle defect PLGA; TGF-B1 +BMP-2 [160]  
2011 Condyle Coral [161]  
2011 Disc UB-ECM [162]  
2012 Condyle Coral [163]  
2012 Disc UB-ECM [164]  
2013 Disc PLA [88]  
2013 Condylectomy HA+Collagen+PRP [165]  
2014 Synovial membrane Collagen [166]  
2014 Disc defect Fibrin+Chitosan [167]  
2015 Disc defect Collagen [168]  
2016 Disc defect PCL+PLGA [87]  
2016 Disc Collagen/Gelatin/Matrigel [45]  
2017 Condyle CCS, PCL/HA, PGA+PLA [169]  
2017 Disc defect Collagen [170]  
CAD/CAM, computer aided design/computer aided manufacturing; CCS; cartilage cell 
sheet; FGF, fibroblast growth factor; Fib, fibrinogen; GFs, growth factors; HA, 
hydroxyapatite; OC, osteochondral; PCL, polycaprolactone; PLA; poly lactide acid; 
PGA, poly glycolic acid; PLGA, poly lactic-co-glycolic acid; PRP, platelet-rich 
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plasma; rhBMP-2, recombinant bone morphogenetic protein-2; TGF-b, transforming 
growth factor beta; Throm, Thrombin; UB-ECM, urinary bladder extracellular matrix. 
 
The next publication using 3D printing for TMJ TE in an animal model was not 
reported until 2016. Tarafder et al.  [87] printed polycaprolactone (PCL) + poly lactic-
co-glycolic acid (PLGA) scaffolds with incorporated microspheres of growth factors 
(GFs) for TMJ disc defects in rabbits. By incorporating a combination of transforming 
growth factor β3 (TGF-β3) and connective tissue growth factor (CTGF) in the 
scaffolds, successful regeneration of disc perforations was observed after 4 weeks 
without implanted cells – compared to GF-free scaffolds. This illustrates the 
endogenous regenerative cell potential in an orthotopic site and the power of advances 
in fabrication methods for tailoring the scaffold properties, with temporal release of 
GFs. The strategy of GF-functionalized scaffolds could hold promise for ectopic 
differentiation of MSC in Study I.  
Based on the review findings, it was decided to continue using a natural polymer 
scaffold to ensure biocompatibility and biodegradability, in combination with BMSC. 
Furthermore, 3D printed scaffold fabrication was selected on the basis of the promising 
results from one of the most recent publications [87]. This would allow the scaffold 
geometry to be customized and the porosity to be controlled. Moreover, the cell density 
used in Study I would need to be increased and in vitro chondrogenic differentiation of 
BMSC would be required.  
 3D printing of gelatin (Studies III & IV) 
Natural polymer hydrogels are able to simulate native ECM. Considering the 
abundance of COL1 in fibrocartilage, it would have been logical to continue using the 
biomaterial from Study I. However, collagen is expensive, with slow gelation, making 
it less than ideal for 3D printing, which involves considerable ‘trial and error’ [97]. 
Gelatin has the same advantages of biocompatibility and cell-adhesion properties [97, 
171], but hydrolysis of COL1 combined with well-controlled manufacturing processes 
makes it less antigenic [97]. Moreover, gelatin is far less expensive, exhibits high 
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gelation for hydrogel formation and is reported to show promise for CTE [94, 172]. It 
is thus an attractive candidate for 3D printed scaffold fabrication for TMJ TE. Gelatin 
has been used in three of the studies included in the systematic review, but in all cases 
combined with other polymers – and none for 3D printing. Gelatin has been used in 
scaffold biomaterials for a variety of applications [94], from regeneration of adipose 
tissue [172], liver tissues [173], nerve tissue and cardiac tissue constructs to bone, 
among others [94]. For CTE, gelatin has been used as a constituent in composite 
scaffolds, freeze-dried porous scaffolds [108] and hydrogels [174]. Nevertheless, there 
are few studies reporting the application of gelatin hydrogel for TMJ TE.  
When 3D porous scaffolds of gelatin are made by electrospinning and freeze-drying, 
there is only limited capacity to control the macroscopic pores. A major advantage of 
3D printing is the ability to control macroporosity [175]. Layer-by-layer hydrogel 3D 
printing is a rapidly advancing method [176]. It provides high accuracy, controlled 
macroporosity and the potential to customize scaffolds to fit the defect [176]. Freeze-
drying of the 3D printed hydrogel scaffold results in dual porosity, as the printed pores 
are accompanied by the microscopic pores of the strands.  
3D printing of gelatin requires a high material concentration with consequently high 
viscosity and decreased printability [177]. For this reason, gelatin has been blended 
with different biopolymers to enhance the viscosity [177, 178]. Gelatin can form gels 
at temperatures below 30 ºC, facilitated by the transformation of the random coiling of 
the molecules to triple helical formations [97]. This thermo-reversible property 
demonstrates a memory of viscosity [179], and cooling the hydrogel to jelly in the 
refrigerator before heating it to printable temperatures increases the printability, 
compared to cooling down a heated gel. In the current project, large structures with 16 
well-defined layers of 10 % gelatin were successfully printed without co-deposition of 
other materials. The printed project was designed by software (Bioplotter RP) and the 
object was sliced horizontally at a thickness of 80 % of the nozzle size, as 
recommended by the manufacturer. This was done to allow for the decrease in vertical 
dimension due to the overlap of the soft polymer strands (Figure 10).  The application 





Figure 10. Schematic illustration of the overlap of the printed strands in the vertical 
dimension. 
The ratio between the inner nozzle diameter and the printed strands revealed an 
increased spreading ratio of the strands from layer two to layer 8 and layer 16 (Figure 
11). The overall spreading ratio was 1.3, compared to the theoretical strand width of 
400 µm. The increased strand width can be linked to the heightened distance between 
the nozzle and the cooled platform (4 °C) leading to less thermal stabilization of the 
strands. Furthermore, any discrepancy between the strand thickness and the sliced 
digital object will accumulate throughout the process. For optimal printing accuracy, 
the ratio should be ‘one’. This is very challenging when printing hydrogels – and 
despite the comprehensive optimization of the printing parameters, there is potential 






Figure 11. Spreading ratio (A) during printing and shrinkage (B) after freeze-drying 
of layer 2, 8, 16 and overall.  
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 Crosslinking of printed gelatin scaffolds (Studies III & IV) 
Because of its thermo-reversibility, gelatin depends on proper crosslinking to avoid 
dissolving in a physiological environment and to improve the mechanical properties 
[180]. Traditional crosslinkers such as GTA have disadvantages, for example 
cytotoxicity of the agents and their degradation products, due to the aldehyde groups 
[181, 182]. Therefore, optional natural crosslinkers were explored. As a result of the 
crosslinking reactions, the white freeze-dried scaffolds changed color (Figure 12). 
Genipin resulted in a dark blue color, due to the pigment formation from the covalent 
bond formation with the primary amines [103, 171]. DHT resulted in a light-yellow 
color from the physical crosslinking, ribose in a dense yellow color from the chemical 












Figure 12. Gross images of printed hydrogel, freeze-dried scaffolds, and crosslinking 
by genipin, DHT, ribose and dual crosslinking with DHT + ribose.  
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 Degree of crosslinking, swelling & degradation 
Genipin is reported to be an efficient crosslinker of different natural polymers. The 
reaction can be controlled by the concentration and duration of incubation [183]. 
Solorio et al.  [183] prepared 6 % (w/v) gelatin (Type A and B) microspheres for GFs 
encapsulation using 1 % (w/v) genipin and measured the degree of crosslinking. 
Gelatin type A reached a plateau of 90 % after 24 h, higher than Type B (50 %). De 
Clercq et al.  [184] reported approximately 75 % crosslinking of Type B gelatin 
microspheres crosslinked by 1 % genipin. The effectiveness of genipin has been 
explained by the ‘range’ of the crosslinker. In short-range crosslinks, genipin can 
chemically react with amino groups within a gelatin molecule and between two 
adjacent gelatin molecules. Genipin can also establish long-range intermolecular 
crosslinks and consume two free amino groups [185].  
In Study IV, the degree of crosslinking was measured as a percentage of crosslinked 
primary amines. DHT had the lowest degree of crosslinking at 14.5 ± 1.9 %, compared 
with 31.8 ± 5.6 % for ribose. Highest were the dual-crosslinked samples at 44.4 ± 8.5 
%. This is close to the sum of the two single crosslinkers and demonstrates the 
differences in crosslinking mechanisms. In DHT treatment, the high temperature, 
combined with pressure, removes bound water and results in intermolecular crosslinks 
as a result of amide formation or esterification [108]. Ribose chemically induces 
intermolecular bridges between the lysine residues of one gelatin molecule and the 
arginine residues of other gelatin molecules [118]. By combining the two methods, the 
number of crosslinked amines increased. The effect of ribose crosslinking can be 
adjusted by the concentration, reaction time and temperature [186]. At 32 %, the degree 
of crosslinking was higher than reported in the literature for 1 % collagen (26 %), 
crosslinked by the same protocol but with a higher ribose concentration [118]. The 
values are comparable, but the difference could be due to structural differences between 
collagen and gelatin. A study comparing DHT and genipin (1.5 %) crosslinking of 5 % 
(w/v) type A gelatin using the same protocol, revealed a marginally higher degree of 
crosslinking from genipin (31 %) than DHT (30 %) [108]. However, the variations in 
the published data on the degree of crosslinking of gelatin-genipin structures can be 
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attributed to variations in the type of gelatin, the concentrations of gelatin or genipin, 
the shape and size of the structures as well as the time and temperature of the 
crosslinking. 
After printing, the hydrogel was frozen, leading to ice crystal formation of the water 
molecules. Freeze-drying evaporated the crystalized water and resulted in micropores 
in the strands. This led to shrinkage of the initial printed strand dimensions as measured 
in Study IV. DHT treatment resulted in the highest shrinkage. This could be attributed 
to the physical treatment of heat under vacuum, which removes additional bound water 
from the samples. Ribose treatment includes freeze-drying before and after 
crosslinking. This resulted in less shrinkage than DHT. It is noteworthy that the least 
shrinkage was observed in dual-crosslinked samples exposed first to DHT treatment, 
followed by ribose and freeze-drying. However, the variations in shrinkage did not 
significantly affect differences in object volume, surface area or open porosity 
measured by µCT. The porous strands from the freeze-drying process were evident in 
all groups and confirmed by SEM. However, SEM also disclosed differences in the 
micro-porosity. Crosslinking by genipin (Figure 13A) in Study III resulted in smooth-
surfaced porous strands. In Study IV (Figure 13B), DHT treatment resulted in lamellar 
pores, while ribose resulted in more spherical pores. Dual crosslinking resulted in the 






Figure 13. Micro CT 3D-reconstruction of the scaffolds and SEM images from 
genipin-crosslinked scaffolds in Study III (A) and DHT, ribose and dual-crosslinked 
scaffolds in Study IV (B).  
 70
Gelatin is degraded by hydrolysis and enzymatic actions [97]. Enzymatic resistance is 
important in a physiological environment, to avoid excessively rapid degradation. In 
Study IV (Figure 14), the dual crosslinking method with the highest degree of 
crosslinking resulted in the least enzymatic degradation (13.5 %). It was of interest to 
note that DHT, with the lowest degree of crosslinking (61.6 %) was more resistant to 
collagenase than ribose (79.4 %), indicating that physical crosslinked gelatin is less 
susceptible to collagenase. Crosslinking with ribose can be performed before (pre) or 
after (post) freeze-drying. Comparisons of the methods with collagen have shown post 
freeze-drying, as conducted in Study IV, to be superior [118]. Enzymatic degradation 
was not measured for the gelatin scaffolds in Study III. However, comparison of 
different crosslinkers on gelatin sponges (4 % v/w) revealed enzymatic resistance of 
genipin to collagenase type I to be comparable to the GTA, but with markedly higher 
cell viability and proliferation [180].  
 
Figure 14. Enzymatic degradation of crosslinked scaffolds by DHT, ribose and 
DHT+ribose. **, p < 0.01.  
The capacity to swell is one of the advantages of using hydrophilic porous scaffolds, 
as they can absorb surrounding fluids, e.g. cell culture medium in vitro and synovial 
fluid in vivo, nourishing the cells and simulating the native ECM. The porous strands 
of all the crosslinked scaffolds had high swelling capacity (Figure 15A). This was 
measured as mass gain over time. Of all the crosslinked scaffolds, genipin (Study III) 
had the lowest values after 48 h (364 %). In Study IV, ribose had the highest water 
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uptake, with a swelling of 1343. 3 ± 200.8 % weight gain after 48 h, while swelling of 
848.3 ± 57.4 % and 828.8 ± 69.2 % was recorded for DHT and dual-crosslinked 
scaffolds, respectively. The superior swelling capacity of ribose can be attributed by 
the hydroxyl groups introduced by the sugar, and their ability to form hydrogen bonds 
to water molecules [187]. Dual crosslinking with DHT seemed to diminish this effect. 
The swelling properties can also be related to the degree of crosslinking, as it affects 
the free amine groups available for binding water [187], and it may indicate that genipin 
has a higher degree of crosslinking than DHT. 
The stability of the scaffolds was tested in basal medium (Figure 15B). After 14 days, 
genipin-crosslinked scaffolds (Study III) were outperformed by the dual-crosslinked 
scaffolds (Study IV), which were the most stable after 21 days of culture. The genipin 
and the ribose-crosslinked scaffolds had the same percentage of mass loss, while the 
DHT scaffolds were the least stable at all timepoints. The inferior stability of DHT 
treated samples in complete medium, compared to ribose, correlates with the degree of 
crosslinking, but not with the enzymatic resistance, as ribose treated samples were 
more susceptible to collagenase. These results are not in concordance with Shankar et 
al.  [108], reporting that under physiological conditions, DHT crosslinked gelatin was 
more stable than genipin – despite the comparable extent of crosslinking. However, in 
the referred study, genipin had superior swelling properties to DHT, which may explain 
the increased hydrolysis. Furthermore, the superior stability of genipin crosslinked 
scaffolds compared to the DHT could be related to differences in degree of 
crosslinking, which would correlate with the inferior swelling capacity [108].  
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Figure 15. Swelling properties (A) and stability in complete medium of the 
differently crosslinked scaffolds for 21 days. Note: Genipin was conducted in 
a separate experiment (Study III) and the experimental conditions may not have 
been exactly the same as the others.  
 Crosslinking affects the mechanical properties of 3D printed 
gelatin scaffolds (Studies III & IV) 
During normal function, the fibrocartilaginous structures of the TMJ are subjected to 
dynamic forces. Scaffolds for such applications should be characterized in terms of 
mechanical properties [7]. In Study III, the compressive modulus in a dry state was 
higher for non-crosslinked scaffolds (9.49 ± 3.93 MPa) than for those crosslinked with 
genipin (4.52 ± 1.51 MPa). In wet conditions, the non-crosslinked samples collapsed 
and were not measurable, and the genipin crosslinked samples dropped to 191 ± 0.01 
kPa (Figure 16). After maximum compression of the dry samples and 2 min rehydration 
in PBS, the genipin crosslinked samples fully recovered their initial dimensions, while 
there was minimal recovery of the non-crosslinked samples (3.75 %). In Study IV, the 
DHT crosslinked samples had the highest Young’s Modulus (37.6 ± 13.3 kPa) in wet 
conditions and ribose had the lowest values (2.0 ± 0.5 kPa), significantly lower than 
DHT and dual-crosslinked samples (30.9 ± 10.9 kPa) (Figure 16).  
For load-absorbing structures, elastic properties and the ability to revert to the original 
dimensions after deformation are important. It can also be beneficial for surgical 
implantation in sites with limited access, as they can be compressed into place. To test 
the stress-relaxation properties, a creep test was undertaken in Study IV. After 
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continuous loading for 15 min the ability of the samples to revert to their original 
dimensions was investigated. The strain values of DHT were 53 % immediately after 
release of the load and decreased to 7 % after 15 min recovery. The strain values for 
ribose and dual-crosslinked samples were 19 % and 14 % after loading, and 16 % and 
12 % after recovery, respectively. The dual-crosslinked samples, with the greatest 
degree of crosslinking, exhibited the highest modulus of elasticity. Based on the 
mechanical characterization, this can be attributed to the DHT treatment, rather than 
ribose.  
These findings are not in accordance with reports in the literature, whereby genipin 
(16.2 ± 0.3 kPa) is reported to be inferior to DHT (54.4 ± 3.8 kPa) crosslinked scaffolds 
[108]. However, the results were achieved under different experimental conditions. 
Although, both tests were conducted in a wet state, the scaffolds in Study IV were 
soaked for 24 h at 37 °C pre-testing, as in the reported protocol [108]. This makes the 
comparison of Studies III and IV less valid, and favors an overestimation of mechanical 
properties of the genipin crosslinked samples. Nevertheless, the values are far from 
those of the native TMJ disc and condylar cartilage, which limits potential applications 











Figure 16. Young’s Modulus of the different crosslinked gelatin scaffolds.  
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 BMSC characterization and cell aggregate formation (Study 
III) 
When cells are isolated from new donors, it is important that donor variation is taken 
into account, by characterizing differentiation capacity in vitro [54].  In Studies I and 
IV rBMSC were sourced from the biobank at the Department of Clinical Dentistry, 
UiB. The uniform genetic background and controlled housing conditions of rats, 
circumvents the issue of donor variability associated with human donors [189]. 
In Study III, hBMSC from two donors were used. The adipogenic and osteogenic 
differentiation potential of hBMSC was confirmed via Oil red O staining (Figure 17A) 
of intracellular lipid vesicles (14 days) and Alizarin red staining (Figure 17B) of 
calcium deposits (21 days), respectively; no staining was observed in non-induced 
control cells.  
While adipogenic and osteogenic differentiation were investigated in monolayers, 
chondrogenic differentiation was tested in 3D pellet cultures. Aggregation of MSC is 
considered essential for chondrogenesis, simulating the developmental stages of 
embryogenesis [190]. This facilitates cell-to-cell contact through adhesion proteins 
(e.g. N-cadherin), which activates intra- and extracellular signaling pathways essential 
for MSC chondrogenesis [191]. Paraffin sections of chondrogenically induced hBMSC 
stained positively for Alcian blue (Figure 17C) after 28 days, demonstrating synthesis 
of cartilaginous proteoglycan matrix [54], while the pellets cultured in control medium 
had a more irregular shape and pale staining. 
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Figure 17. Staining of hBMSC cultured in control and (A) adipogenic, (B) osteogenic 
and (C) chondrogenic defined medium.  
The cell pellets and spheres formed during the first 24 h after centrifugation in tubes 
and microwell plates, respectively (Figure 18). The pellets were visible at the bottom 
of the tubes as white, rounded aggregates of approximately 1 mm diameter. The spheres 
were localized at the bottom of the microwells, uniform in size and shape, with a 
diameter of approximately 250 µm. Live/dead assay after 1 and 4 days revealed viable 




Figure 18. Images of pellet and sphere(s) after 24 h (top), live/dead assay after 1 day 
(middle) and 4 days (bottom). Red signal (dead cells), green signal (living cells).   
 Indirect cytotoxicity testing of genipin (Study III) 
Because of the cytotoxicity of traditional crosslinkers, e.g. GTA, genipin has been used 
as an alternative for crosslinking of several biomaterials [181, 192]. Genipin is a natural 
compound, derived from hydrolysis of the Gardenia fruit and is reported to be 10 000 
times less toxic than GTA [181]. The cytotoxicity of genipin is however, reported to 
be dose-dependent [193]: hence in Study III, the cytotoxicity of 1 % genipin (v/w) to 
hBMSC was investigated.  
Cell cultures of hBMSC monolayer in genipin-extraction medium and control medium 
demonstrated similar trends with respect to proliferation and viability. As measured 
with alamarBlue, both groups proliferated significantly from day 1 to day 3. The cell-
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morphology was similar (Figure 19A), and the viability of the hBMSC, equal (Figure 
19B). It was concluded that at the applied concentration of 1 %, genipin was non-
cytotoxic for hBMSC.  
Figure 19. Morphology (A) and live/dead staining (B) of hBMSC cultured in control 
medium and genipin extraction medium. Red signal (dead cells), green signal (living 
cells).   
 Cell-scaffold interactions (Studies III & IV) 
Cell seeding is a crucial step for in vitro cell cultures on 3D scaffolds [194]. To 
facilitate growth and differentiation, the seeded cells should be widely distributed and 
attached throughout the pores of the scaffold. The optimal cell seeding density of 
BMSC differs, depending on the targeted tissue and lineage of differentiation. 
Generally, chondrogenic differentiation requires a higher cell density than osteogenic 
differentiation, given that the cells require proximity for cell communication and 
differentiation. Bornes et al.  [135] investigated the optimal seeding density of BMSC 
for in vitro chondrogenic differentiation. Monolayer expanded BMSC were seeded 
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onto collagen scaffolds in the range of 0.5-50 × 106 cells/cm3. Based on gene 
expression, histological staining and GAG quantification, the authors concluded that 
the optimal range for hyaline CTE was from 5-10 × 106 cells/cm3, while the lower 
range of 1-5 × 106 cells/cm3 was optimal for fibrocartilage-related COL1 expression. 
The selected seeding number of 1.2 × 106 cells per scaffold (4.8 × 106 cells/cm3) is at 
the upper range of the recommended seeding density for fibrocartilage.   
In porous scaffolds, seeding efficiency is rarely 100 %, as some cells fail to attach and 
are lost from the structure. The printed design of the scaffold, with open macroporosity, 
led to lower cell seeding efficiency than for moulded and freeze-dried scaffolds with 
smaller, closed pores which can entrap more cells. Regardless of fabrication method, 
cell seeding efficiency is important in order to estimate the actual cell numbers attached 
to the scaffolds. In Study III, 57.3 % of the seeded hBMSC attached to the scaffold. 
This was higher than observed for the rBMSC in Study IV on DHT crosslinked 
scaffolds (51.6 %). Ribose- and dual-crosslinked scaffolds were significantly lower, at 
34 % and 38 %, respectively.  
The shift for every third and fourth layer of the scaffolds created physical barriers 
which facilitated cell attachment sites. This strategy has been reported to be a simple 
means of increasing the cell seeding efficiency of 3D printed scaffolds [195]. However, 
the reported cell seeding efficiency of less than 60 % can be linked to the porosity. 
Ribose had the largest pores and lowest cell seeding efficiency. Using the same strategy 
with PCL scaffolds, Declercq et al.  [195] increased the cell seeding efficiency from 
52 % to 66 %. However, these scaffolds had a porosity of 66-70 %, compared to 87-93 
% for the different gelatin scaffolds. By decreasing the strand distance, the seeding 
efficiency could be improved. However, this led to decreased printability and 
reproducibility of the structures, as the strands tended to adhere to each other when the 
nozzle changed direction in the x-y plane.   
The morphology of the attached cells was documented by SEM (Figure 20). Images 
after 24 h attachment revealed intergroup differences. Cells attached to ribose appeared 
more rounded and clumped whereas the others exhibited more spreading, spindle-
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shaped morphology. This could be related to the stiffness of the material, attributable 
to the different crosslinkers, as ribose was the mechanically weakest material in wet 









Figure 20. SEM images of cells attached to the different crosslinked gelatin scaffolds.  
To evaluate the distribution on the scaffolds (Study III) fluorescent staining (phalloidin 
and DAPI, Figure 21) were used. Cells were observed both on the surface and in the 
depths of the porous scaffold.  
Figure 21. Cell distribution on genipin crosslinked scaffolds after 1 and 4 days. Green 
signal (phalloidin/actin), blue signal (DAPI, nuclei).  
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Viability of hBMSC (Study III) and rBMSC (Study IV) on the scaffolds was evaluated 
by live/dead assay (Figure 22). Qualitatively, all scaffolds supported cell viability and 
distribution after 1 and 4 days. Cross-sections and bottom view disclosed cell 
distribution through all layers. In Study IV, cells observed on the ribose crosslinked 
scaffolds were less viable than those on the DHT and dual-crosslinked scaffolds. This 
may be related to the differences in cell seeding efficiency, as no differences in dead 
cells were observed. Based on these findings, it was concluded all the crosslinker 
agents used for the 3D printed gelatin scaffolds were non-cytotoxic.  
Figure 22. Cell viability after 1 day for Studies III and IV. Red signal (dead cells), 
green signal (living cells).  
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Cell-seeded scaffolds from all groups (Studies III and IV) supported cell proliferation 
from day 4 until day 7 in basal medium. Chen et al.  [196] reported that the stiffness of 
the gelatin scaffolds affected CC proliferation. This may explain the poorer 
proliferation of rBMSC on ribose crosslinked scaffolds, compared to the significantly 
higher proliferation on the dual-crosslinked scaffolds. Another explanation is the 
scaffolds’ ability to resist cellular contraction and retain their porosity, which 
stimulates cell proliferation [196].  
5.10. Chondrogenic differentiation of BMSC (Studies III & IV) 
All groups in Study IV supported gene markers for chondrogenesis and hypertrophy 
after 7 and 21 days (Figure 23). The main chondrogenic transcription factor, SOX9, 
was stable in all groups, with the highest, though non-significant level in the DHT 
group. Expressions of ACAN, the cartilage-specific proteoglycan core protein, were 
equal at day 7 and decreased significantly in all groups after 21 days. This explains the 
minimal GAG-formation after 21 days in all groups. Despite the significantly higher 
ACAN expression in dual-crosslinked scaffolds after 21 days, differences in GAG-
formation were non-significant. This could indicate inadequate differentiation of 
rBMSC to the chondrogenic phenotype, as others have reported 3-fold higher GAG 
formation after 14 days of culture of CC seeded DHT crosslinked gelatin scaffolds 
[108]. The smaller scaffold porosity (390 ± 14 µm) may also have influenced the 
outcome. At 21 days, DHT had significantly higher COL1 expression than ribose, with 
intermediate levels of expression by the dual-crosslinked scaffolds. The ratio of COL1 
to COL2 is one of the main differences between hyaline and fibrocartilage [7]. While 
fibrocartilage contains mainly COL1, hyaline cartilage is dominated by COL2. In the 
current study, COL2 expression was upregulated, while COL1 was stable or decreased 
(ribose) – indicating differentiation towards hyaline cartilage rather than fibrocartilage. 
The hypertrophy marker, COL10, was stable and close to equal in all three groups.  
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Figure 23. Gene expression of a selection of gene-markers in Study IV. *, p < 0.05; 
**, p < 0.01. 
In Study III, hBMSC pellets served as a reference group. Compared to both the pellet 
and the sphere group, gene expression for all markers was lower in the scaffold group, 
at all timepoints. These findings were most pronounced for the chondrogenic markers 
SOX9 and ACAN. This can be related to the differences in the 3D microenvironments 
and is in accordance with reports in the literature, that spheres have superior 
differentiation potential [197]. Although in a 3D environment, cells cultured on 
scaffolds are further apart and dispersed than in the aggregated cultures. The 
morphology of the cells in the pellets and spheres was more condensed and spherical – 
while cells cultured on the scaffold appeared spread and spindle-shaped, more closely 
resembling a monolayer manner. Furthermore, the aggregated cultures induce mild 
hypoxia, activating hypoxia-related cascades, such as upregulation of cell-adhesion 
molecules (e.g. HIF-1α) involved in mesenchymal chondrogenesis [198].  
Despite the lower expression of chondrogenic genes in the scaffold-group, upregulation 
followed the same trends and chondrogenic differentiation was confirmed by 
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immunofluorescence (SOX9 and COL1, Figure 24).  After 21 days, the hypertrophy-
related marker, COL10, was highly upregulated, particularly in the spheres (80-fold), 
but also in the pellets (20-fold). It was of interest to note that COL10 was expressed 
marginally in the scaffold-group (2-fold). Upregulation of COL10 is one of the 
challenges for chondrogenic differentiation of MSC, as it is reported to serve as a 
framework for subsequent calcification of articular cartilage [199]. This argument has 
been used to justify the use of mature CC, despite donor-site morbidity and the need 
for further surgical intervention [38]. Therefore, the ability of genipin crosslinked 
scaffolds to limit hypertrophy of differentiated hBMSC may be important for future 
experiments and may achieve successful cartilage maturation without calcification of 
the engineered constructs.  
Alcian blue staining was positive for all groups. Qualitatively, the staining intensity 
was highest for spheres, followed by pellets and scaffolds. Sarem et al.  found a direct 
correlation between the initial aggregate cell number and acceleration of chondrogenic 
differentiation, independent of extrinsic inductive factors [190]. They gradually 
reduced the cell numbers from 5 × 105 to 70 × 104 per pellet, demonstrating that the 
smallest aggregates stained positive for GAG formation using Alcian blue, even after 
7 days in the absence of TGF-β1. In Study III, non-induced spheres were not cultured, 
but this study provides evidence of GF-independent activation of the chondrogenic 
program in MSC, by limiting the size of the aggregates. This intrinsic activation can 
therefore explain the superior GAG formation of the spheres and the lower 
chondrogenic differentiation of the more scattered hBMSC on the scaffolds. Thus, 















Figure 24. Immunofluorescence staining for SOX9 and COL1 (green signal) in Study 
III. Nuclei stained with DAPI (blue signal).  
In summary, 3D printed scaffolds combined with cell therapy is a promising strategy 
for customized treatment of degenerative TMJ conditions. The mechanical properties 
of 3D printed hydrogel scaffolds limit their application to smaller-sized defects. By 
combining gelatin with a thermoplastic polymer, it can potentially be used for load-
bearing applications of the TMJ. Individualized clinical cell therapy is associated with 
considerable costs. However, the impact of an effective treatment of degenerative joint 
disease will be significant for the suffering patient’s quality of life and the financial 
burden on society. Hopefully, future joint collaborations between clinicians and 
researchers can provide a viable treatment options for the vast majority.  
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6.  Conclusions 
The current project represents a preliminary exploration of factors of importance in 
the TE approach of cartilaginous structures of the TMJ. Based on the results, the 
following conclusions can be drawn:   
• Angiostatin reduces the angiogenic and inflammatory response to collagen 
scaffolds seeded with rBMSC in vivo, although this itself does not induce 
chondrogenesis (Study I).  
• The current preclinical evidence indicates superior regeneration of TMJ 
cartilage tissues by scaffolds seeded with chondrogenic cells, compared to cell-
free scaffolds. Differentiation of cells pre-implantation is advantageous (Study 
II).  
• Gelatin demonstrated high suitability for scaffold fabrication via 3D printing 
(Studies III and IV). 
• 3D printed gelatin scaffolds crosslinked with genipin are cytocompatible, 
support the chondrogenic differentiation and limits the hypertrophic tendency 
of hBMSC in vitro (Study III).  
• Dual crosslinking of 3D printed gelatin scaffolds with DHT and ribose enhances 
the mechanical and degradation properties, and support chondrogenic 
differentiation of rBMSC in vitro (Study IV).  
• The mechanical properties of 3D printed gelatin limit its potential application to 
smaller, non-load bearing defects (Studies III and IV).   
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7.  Future perspectives 
The future of 3D printing technology and MSC in TMJ TE seems promising. These 
technological developments will allow medicine to be tailored toward specific patients. 
Recently, 3D printed TMJ prostheses with customized design have been introduced in 
clinical applications [200]. The use of autologous MSC is approved for clinical trials 
in Europe and their safety and efficacy have been reported for maxillofacial bone 
regeneration [201]. For clinical trials, safe and approved biomaterials must be used in 
combination with the MSC. Although gelatin is classified as GRAS by the FDA, a 
scaffold combining gelatin and MSC requires long and expensive clinical approval 
procedures. Moreover, the mechanical properties of the 3D printed gelatin scaffolds 
are not sufficient for load-bearing applications. The use of mechanically stronger and 
FDA-approved materials such as PCL can facilitate the translation of 3D printing 
technology to the clinic. However, toward human translation, the safety and efficacy 
of these tissue engineered TMJ 3D printed scaffolds must be evaluated in a suitable 
large animal model. Minipigs represents one of the more clinical translational animal 
models based on their TMJ anatomy and biology [42, 142] and would offer a suitable 
platform to test new TMJ TE strategies. This requires the development of an 
appropriate defect model and the surgical techniques to fix the scaffolds into the TMJ. 
Altogether, the need for further research is necessary to pave the path of TMJ 3D 
printed scaffolds from bench to bedside.  
 
Based on the results of the current thesis, the future research should include: 
• Functionalization of 3D printed gelatin with angiostatin. The dose and 
controlled release should be further optimized to maximize its effect on MSC.  
• Although gelatin demonstrated high 3D printability, the scaffold design should 
be further optimized with respect to internal architecture and porosity. Co-
printing of gelatin hydrogel between strong thermoplastic polymeric filaments 
such as PCL should be adopted to improve the mechanical properties of the 
scaffolds. 
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• The chondrogenic potential of MSC spheres printed in gelatin hydrogel should 
be further investigated in vitro and in vivo.  
• To facilitate clinical translation, the regenerative potential of 3D printed gelatin 
scaffolds with MSC should be investigated in orthotopic TMJ models, e.g. disc 
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